| Year |
Citation |
Score |
| 2023 |
Scheich S, Chen J, Liu J, Schnutgen F, Enssle JC, Ceribelli M, Thomas CJ, Choi J, Morris V, Hsiao T, Nguyen H, Wang B, Bolomsky A, Phelan JD, Corcoran S, ... ... Staudt LM, et al. Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas. Cancer Discovery. PMID 37141112 DOI: 10.1158/2159-8290.CD-22-1401 |
0.349 |
|
| 2021 |
Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin Y, Bryant BR, Petrus MN, Bachy E, Huang DW, Yang Y, Green PL, Hasegawa H, Maeda M, Goto H, ... ... Staudt LM, et al. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma. Blood. PMID 34818414 DOI: 10.1182/blood.2021012734 |
0.305 |
|
| 2021 |
Pighi C, Cheong TC, Compagno M, Patrucco E, Arigoni M, Olivero M, Wang Q, López C, Bernhart SH, Grande BM, Poggio T, Langellotto F, Bonello L, Dall'Olio R, Martínez-Martín S, ... ... Staudt LM, et al. Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma. Blood Advances. 5: 5239-5257. PMID 34625792 DOI: 10.1182/bloodadvances.2021005682 |
0.365 |
|
| 2021 |
Chiodin G, Allen JD, Bryant D, Rock P, Martino EA, Valle-Argos B, Duriez PJ, Watanabe Y, Henderson I, Blachly JS, McCann KJ, Strefford JC, Packham G, Geijtenbeek TB, Figdor C, ... ... Staudt LM, et al. Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior. Blood. PMID 34424958 DOI: 10.1182/blood.2021012052 |
0.354 |
|
| 2021 |
Ruiz Cuevas MV, Hardy MP, Hollý J, Bonneil É, Durette C, Courcelles M, Lanoix J, Côté C, Staudt LM, Lemieux S, Thibault P, Perreault C, Yewdell JW. Most non-canonical proteins uniquely populate the proteome or immunopeptidome. Cell Reports. 34: 108815. PMID 33691108 DOI: 10.1016/j.celrep.2021.108815 |
0.47 |
|
| 2020 |
Wilke AC, Doebele C, Zindel A, Lee KS, Rieke SA, Ceribelli M, Comoglio F, Phelan JD, Wang JQ, Pikman Y, Jahn D, Häupl B, Schneider C, Scheich S, Tosto FA, ... ... Staudt LM, et al. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood. PMID 34624079 DOI: 10.1182/blood.2021012081 |
0.31 |
|
| 2020 |
Dersh D, Phelan JD, Gumina ME, Wang B, Arbuckle JH, Holly J, Kishton RJ, Markowitz TE, Seedhom MO, Fridlyand N, Wright GW, Huang DW, Ceribelli M, Thomas CJ, Lack JB, ... ... Staudt LM, et al. Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas. Immunity. PMID 33271120 DOI: 10.1016/j.immuni.2020.11.002 |
0.55 |
|
| 2020 |
Fish K, Comoglio F, Shaffer AL, Ji Y, Pan KT, Scheich S, Oellerich A, Doebele C, Ikeda M, Schaller SJ, Nguyen H, Muppidi J, Wright GW, Urlaub H, Serve H, ... Staudt LM, et al. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A. Proceedings of the National Academy of Sciences of the United States of America. PMID 33020271 DOI: 10.1073/pnas.2007946117 |
0.37 |
|
| 2020 |
Pittaluga S, Nicolae A, Wright GW, Melani C, Roschewski M, Steinberg S, Huang D, Staudt LM, Jaffe ES, Wilson WH. Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. Blood Cancer Discovery. 1: 155-161. PMID 32914098 DOI: 10.1158/2643-3230.BCD-20-0009 |
0.398 |
|
| 2020 |
Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, Béguelin W, Lee TC, Kim Y, Chin CR, Yewdell WT, Raught B, Phillip JM, Jiang Y, Staudt LM, et al. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. Cell. PMID 32619424 DOI: 10.1016/J.Cell.2020.05.049 |
0.452 |
|
| 2020 |
Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, Wang JQ, Schmitz R, Morin RD, Tang J, Jiang A, Bagaev A, Plotnikova O, Kotlov N, Johnson CA, ... ... Staudt LM, et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 37: 551-568.e14. PMID 32289277 DOI: 10.1016/J.Ccell.2020.03.015 |
0.376 |
|
| 2020 |
Phelan JD, Staudt LM. CRISPR-based technology to silence the expression of IncRNAs. Proceedings of the National Academy of Sciences of the United States of America. PMID 32245807 DOI: 10.1073/Pnas.2003702117 |
0.332 |
|
| 2020 |
Choi J, Phelan JD, Wright GW, Häupl B, Huang DW, Shaffer AL, Young RM, Wang Z, Zhao H, Yu X, Oellerich T, Staudt LM. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14. Proceedings of the National Academy of Sciences of the United States of America. PMID 32127472 DOI: 10.1073/Pnas.1921187117 |
0.467 |
|
| 2020 |
Ennishi D, Healy S, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, ... ... Staudt LM, et al. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. Nature Medicine. PMID 32094924 DOI: 10.1038/S41591-020-0757-Z |
0.464 |
|
| 2019 |
Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone WG, Bouska A, D'amore F, Bjerregård Pedersen M, Pileri SA, Agostinelli C, Feldman AL, Rosenwald A, Ott G, Mottok A, ... ... Staudt LM, et al. Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. Blood. PMID 31562134 DOI: 10.1182/Blood.2019000779 |
0.379 |
|
| 2019 |
Young RM, Phelan JD, Wilson WH, Staudt LM. Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment. Immunological Reviews. 291: 190-213. PMID 31402495 DOI: 10.1111/Imr.12792 |
0.469 |
|
| 2019 |
Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, et al. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801994. PMID 30939090 DOI: 10.1200/Jco.18.01994 |
0.327 |
|
| 2019 |
Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, Patti C, Belada D, Samoilova O, Suh C, Leppä S, Rai S, Turgut M, Jurczak W, Cheung MC, ... ... Staudt LM, et al. Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802403. PMID 30901302 DOI: 10.1200/Jco.18.02403 |
0.43 |
|
| 2019 |
Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, ... ... Staudt LM, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. PMID 30782609 DOI: 10.1182/Blood-2018-09-872549 |
0.44 |
|
| 2019 |
Wei J, Kishton RJ, Angel M, Conn CS, Dalla-Venezia N, Marcel V, Vincent A, Catez F, Ferré S, Ayadi L, Marchand V, Dersh D, Gibbs JS, Ivanov IP, Fridlyand N, ... ... Staudt LM, et al. Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance. Molecular Cell. PMID 30712990 DOI: 10.1016/J.Molcel.2018.12.020 |
0.506 |
|
| 2019 |
Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, ... ... Staudt LM, et al. Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. PMID 30617194 DOI: 10.1182/Blood-2018-09-871418 |
0.429 |
|
| 2019 |
Melani C, Lakhotia R, Pittaluga S, Miljkovic M, Portell C, Farah R, Juanitez A, Chou L, Steinberg S, Jaffe E, Staudt L, Roschewski M, Wilson W. PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B-CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS Hematological Oncology. 37: 332-333. DOI: 10.1182/Blood-2019-125990 |
0.373 |
|
| 2019 |
Roschewski M, Izumi R, Hamdy A, Patel MR, Arkenau H, de Vos S, Reagan PM, Zinzani PL, Davies A, Pagel JM, Vose JM, Bitman B, Brock G, Clark E, Frigault MM, ... ... Staudt L, et al. PRISM: A Platform Protocol for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Blood. 134: 2869-2869. DOI: 10.1182/Blood-2019-125939 |
0.324 |
|
| 2019 |
Choi J, Phelan JD, Young RM, Oellerich T, Huang DW, Shaffer AL, Staudt L. KLHL14 Is a Tumor Suppressor in Diffuse Large B-Cell Lymphoma Blood. 134: 2766-2766. DOI: 10.1182/Blood-2019-125137 |
0.508 |
|
| 2019 |
Ishio T, Shimono J, Kumar S, Lin Y, Bachy E, Petrus MN, Yang Y, Maeda M, Goto H, Hashino S, Teshima T, Waldmann TA, Staudt L, Nakagawa M. Genome-Wide CRISPR Library Screening Identifies CDK6 As Genetic Vulnerability in Adult T-Cell Leukemia/Lymphoma Blood. 134: 3781-3781. DOI: 10.1182/Blood-2019-124670 |
0.474 |
|
| 2019 |
Johnson P, Balasubramanian S, Hodkinson B, Schaffer M, Parisi L, Shreeve SM, Sun S, Vermeulen J, Sehn LH, Staudt L, Younes A, Wilson W. Clinical Impact of Ibrutinib with R-CHOP in Untreated Non-GCB DLBCL Co-Expressing BCL2 and MYC Genes in the Phase 3 Phoenix Trial Blood. 134: 354-354. DOI: 10.1182/Blood-2019-124443 |
0.332 |
|
| 2019 |
Roschewski M, Melani C, Dunleavy K, Holdhoff M, Swinnen LJ, Glantz M, Portell CA, Svoboda J, Farah R, Lionakis MS, Staudt L, Wilson W. Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS Blood. 134: 2875-2875. DOI: 10.1182/Blood-2019-123552 |
0.369 |
|
| 2019 |
Balasubramanian S, Wang S, Major C, Hodkinson B, Schaffer M, Sehn L, Johnson P, Zinzani P, Carey J, Liu G, Loefgren C, Shreeve M, Sun S, Zhuang S, Vermeulen J, ... Staudt L, et al. CONCORDANCE BETWEEN IMMUNOHISTOCHEMISTRY AND GENE EXPRESSION PROFILING SUBTYPING FOR DIFFUSE LARGE B-CELL LYMPHOMA IN THE PHASE 3 PHOENIX TRIAL Hematological Oncology. 37: 140-142. DOI: 10.1002/Hon.99_2629 |
0.436 |
|
| 2018 |
Dadashian EL, McAuley EM, Liu D, Shaffer AL, Young RM, Iyer JR, Kruhlak MJ, Staudt LM, Wiestner A, Herman SEM. TLR signaling is activated in lymph-node resident CLL cells and is only partially inhibited by ibrutinib. Cancer Research. PMID 30498085 DOI: 10.1158/0008-5472.Can-18-0781 |
0.391 |
|
| 2018 |
Corces MR, Granja JM, Shams S, Louie BH, Seoane JA, Zhou W, Silva TC, Groeneveld C, Wong CK, Cho SW, Satpathy AT, Mumbach MR, Hoadley KA, Robertson AG, Sheffield NC, ... ... Staudt LM, et al. The chromatin accessibility landscape of primary human cancers. Science (New York, N.Y.). 362. PMID 30361341 DOI: 10.1126/Science.Aav1898 |
0.481 |
|
| 2018 |
Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, ... ... Staudt LM, et al. Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. Blood. PMID 30257882 DOI: 10.1182/Blood-2018-05-851154 |
0.43 |
|
| 2018 |
Wright GW, Wilson WH, Staudt LM. Genetics of Diffuse Large B-Cell Lymphoma. The New England Journal of Medicine. 379: 493-494. PMID 30067933 DOI: 10.1056/Nejmc1806191 |
0.396 |
|
| 2018 |
Nakagawa M, Shaffer AL, Ceribelli M, Zhang M, Wright G, Huang DW, Xiao W, Powell J, Petrus MN, Yang Y, Phelan JD, Kohlhammer H, Dubois SP, Yoo HM, Bachy E, ... ... Staudt LM, et al. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma. Cancer Cell. PMID 30057145 DOI: 10.1182/Blood.V130.Suppl_1.731.731 |
0.437 |
|
| 2018 |
Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, ... ... Staudt LM, et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature. PMID 29925955 DOI: 10.1038/S41586-018-0290-0 |
0.471 |
|
| 2018 |
Clot G, Jares P, Giné E, Navarro A, Royo C, Pinyol M, Martín-Garcia D, Demajo S, Espinet B, Salar A, Ferrer A, Muntañola A, Aymerich M, Rauert-Wunderlich H, Jaffe ES, ... ... Staudt LM, et al. A new molecular assay and genomic complexity predict outcome in conventional and leukemic non-nodal mantle cell lymphoma. Blood. PMID 29769262 DOI: 10.1182/Blood-2018-03-838136 |
0.371 |
|
| 2018 |
Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, ... ... Staudt LM, et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. The New England Journal of Medicine. 378: 1396-1407. PMID 29641966 DOI: 10.1056/Nejmoa1801445 |
0.469 |
|
| 2017 |
Pongas GN, Annunziata CM, Staudt LM. PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma. Oncotarget. 8: 81794-81802. PMID 29137222 DOI: 10.18632/Oncotarget.20864 |
0.459 |
|
| 2017 |
Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, Ordóñez GR, Rovira J, Clot G, Royo C, Navarro A, Gonzalez-Farre B, Vaghefi A, Castellano G, Rubio-Perez C, ... ... Staudt LM, et al. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia. PMID 28804123 DOI: 10.1182/Blood.V128.22.152.152 |
0.463 |
|
| 2017 |
Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican T, Lachel CM, Yu J, Ferro R, Eldorghamy N, Greiner TC, Vose J, Weisenburger DD, Gascoyne RD, Rosenwald A, ... ... Staudt LM, et al. Adult High Grade B-cell Lymphoma with Burkitt Lymphoma Signature: Genomic features and Potential Therapeutic Targets. Blood. PMID 28801451 DOI: 10.1182/Blood-2017-02-767335 |
0.444 |
|
| 2017 |
Jais JP, Molina TJ, Ruminy P, Gentien D, Reyes C, Scott DW, Rimsza LM, Wright G, Gascoyne RD, Staudt LM, Haioun C, Tilly H, Gaulard P, Salles GA, Jardin F, et al. Reliable subtype classification of diffuse large B-Cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay. Haematologica. PMID 28679653 DOI: 10.3324/Haematol.2017.166827 |
0.436 |
|
| 2017 |
Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, ... ... Staudt LM, et al. Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. Cancer Cell. PMID 28552327 DOI: 10.1016/J.Ccell.2017.04.012 |
0.39 |
|
| 2017 |
Souroullas GP, Fedoriw Y, Staudt LM, Sharpless NE. Lkb1 deletion in murine B lymphocytes promotes cell death and cancer. Experimental Hematology. PMID 28435024 DOI: 10.1016/J.Exphem.2017.04.005 |
0.457 |
|
| 2017 |
Czuczman MS, Trněný M, Davies A, Rule SA, Linton K, Wagner-Johnston N, Gascoyne RD, Slack G, Brousset P, Eberhard DA, Hernandez-Ilizaliturri FJ, Salles G, Witzig TE, Zinzani PL, Wright GW, ... Staudt LM, et al. A Phase 2/3 Multicenter, Randomized, Open-Label Study of Lenalidomide vs Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28381416 DOI: 10.1158/1078-0432.Ccr-16-2818 |
0.36 |
|
| 2017 |
Jerkeman M, Hallek M, Dreyling M, Thieblemont C, Kimby E, Staudt L. Targeting of B-cell receptor signalling in B-cell malignancies. Journal of Internal Medicine. 282: 415-428. PMID 28295729 DOI: 10.1111/Joim.12600 |
0.407 |
|
| 2017 |
Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, Jares P, Rauert-Wunderlich H, Royo C, Clot G, Pinyol M, Boyle M, Chan FC, Braziel RM, Chan WC, ... ... Staudt LM, et al. New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016707901. PMID 28291392 DOI: 10.1200/Jco.2016.70.7901 |
0.394 |
|
| 2017 |
Grande BM, Gerhard DS, Griner NB, Casper C, Namirembe C, Omoding A, Orem J, Mbulaiteye SM, Mullighan CG, Sandlund JT, Alexander T, Choi JK, Abramson JS, Gross TG, Noy A, ... ... Staudt LM, et al. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma Blood. 130: 39-39. DOI: 10.1182/Blood.V130.Suppl_1.39.39 |
0.415 |
|
| 2017 |
Webster DE, Phelan JD, Kasbekar M, Shaffer AL, Staudt LM. Abstract PR13: CRISPRi screening with targeted therapeutics classifies functional long non-coding RNAs in DLBCL Molecular Cancer Therapeutics. 16. DOI: 10.1158/1538-8514.Synthleth-Pr13 |
0.353 |
|
| 2017 |
Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel R, Delabie J, Weisenburger D, Song J, Chan J, Cook J, Fu K, Greiner T, Smeland E, ... ... Staudt L, et al. MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE SPECIMENS - AN LLMPP PROJECT Hematological Oncology. 35: 59-60. DOI: 10.1002/Hon.2437_46 |
0.367 |
|
| 2017 |
Young R, Phelan J, Webster D, Roulland S, Wright G, Huang D, Schmitz R, Staudt L. CRISPR-CAS9 GENETIC SCREENS UNCOVER A B CELL RECEPTOR-MYD88 SUPERPATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA Hematological Oncology. 35: 25-25. DOI: 10.1002/Hon.2437_4 |
0.42 |
|
| 2016 |
Walter R, Pan KT, Doebele C, Comoglio F, Tomska K, Bohnenberger H, Young RM, Jacobs L, Keller U, Bönig H, Engelke M, Rosenwald A, Urlaub H, Staudt LM, Serve H, et al. HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B cell receptor signaling. Blood. PMID 28064214 DOI: 10.1182/Blood-2016-06-721423 |
0.452 |
|
| 2016 |
Grajkowska LT, Ceribelli M, Lau CM, Warren ME, Tiniakou I, Nakandakari Higa S, Bunin A, Haecker H, Mirny LA, Staudt LM, Reizis B. Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification. Immunity. PMID 27986456 DOI: 10.1016/J.Immuni.2016.11.006 |
0.36 |
|
| 2016 |
Ceribelli M, Hou ZE, Kelly PN, Huang DW, Wright G, Ganapathi K, Evbuomwan MO, Pittaluga S, Shaffer AL, Marcucci G, Forman SJ, Xiao W, Guha R, Zhang X, Ferrer M, ... ... Staudt LM, et al. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancer Cell. 30: 764-778. PMID 27846392 DOI: 10.1182/Blood.V128.22.1513.1513 |
0.391 |
|
| 2016 |
Rui L, Drennan AC, Ceribelli M, Zhu F, Wright GW, Huang DW, Xiao W, Li Y, Grindle KM, Lu L, Hodson DJ, Shaffer AL, Zhao H, Xu W, Yang Y, ... Staudt LM, et al. Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27799566 DOI: 10.1073/Pnas.1610970113 |
0.48 |
|
| 2016 |
Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludvigsen M, Fu K, Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, ... ... Staudt LM, et al. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia. PMID 27389057 DOI: 10.1038/Leu.2016.175 |
0.42 |
|
| 2016 |
Yang Y, Kelly P, Shaffer AL, Schmitz R, Yoo HM, Liu X, Huang da W, Webster D, Young RM, Nakagawa M, Ceribelli M, Wright GW, Yang Y, Zhao H, Yu X, ... ... Staudt LM, et al. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. Cancer Cell. 29: 494-507. PMID 27070702 DOI: 10.1016/J.Ccell.2016.03.006 |
0.444 |
|
| 2016 |
Knittel G, Liedgens P, Korovkina D, Seeger JM, Al-Baldawi Y, Al-Maarri M, Fritz C, Vlantis K, Bezhanova S, Scheel AH, Wolz OO, Reimann M, Möller P, López C, Schlesner M, ... ... Staudt LM, et al. B cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B cell lymphoma in mice. Blood. PMID 27048211 DOI: 10.1182/Blood-2015-11-684183 |
0.457 |
|
| 2016 |
Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, Yang Y, Webster DE, Rui L, Kohlhammer H, Nakagawa M, Waldmann TA, Staudt LM. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proceedings of the National Academy of Sciences of the United States of America. PMID 26993806 DOI: 10.1073/Pnas.1600557113 |
0.522 |
|
| 2016 |
Dekker JD, Park D, Shaffer AL, Kohlhammer H, Deng W, Lee BK, Ippolito GC, Georgiou G, Iyer VR, Staudt LM, Tucker HO. Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787899 DOI: 10.1073/Pnas.1524677113 |
0.538 |
|
| 2016 |
Leroy K, Jais J, Ruminy P, Gentien D, Reyes C, Scott DW, Rimsza LM, Wright G, Gascoyne RD, Staudt LM, Haioun C, Tilly H, Gaulard P, Salles GA, Molina T, et al. Classification of diffuse large b-cell lymphoma (DLBCL) FFPE samples of the GELA LNH2003 program, using Lymph2Cx assay on the nCounter analysis system. Journal of Clinical Oncology. 34: 7547-7547. DOI: 10.1200/Jco.2016.34.15_Suppl.7547 |
0.39 |
|
| 2016 |
Scott DW, Abrisqueta P, Wright G, Jares P, Slack GW, Mottok A, Royo C, Clot G, Pinyol M, Boyle M, Villa D, Steidl C, Connors JM, Rosenwald A, Staudt LM, et al. Prognostic significance of the proliferation signature in mantle cell lymphoma measured using digital gene expression in formalin-fixed paraffin-embedded tissue biopsies. Journal of Clinical Oncology. 34: 7510-7510. DOI: 10.1200/Jco.2016.34.15_Suppl.7510 |
0.459 |
|
| 2016 |
Wilson WH, sin-Ho J, Pitcher BN, Hsi ED, Friedberg J, Cheson B, Bartlett NL, Smith S, Johnston NW, Kahl BS, Staudt LM, Blum K, Abramson J, Press OW, Fisher RI, et al. Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303 Blood. 128: 469-469. DOI: 10.1182/Blood.V128.22.469.469 |
0.362 |
|
| 2016 |
Yoo HM, Schmitz R, Yu X, Huang DW, Phelan JD, Webster DE, Staudt LM. Genome-Scale ORF Screen for Mediators of NF-κb Activation in DLBCL Blood. 128: 4102-4102. DOI: 10.1182/Blood.V128.22.4102.4102 |
0.44 |
|
| 2016 |
Heavican TB, Yu J, Bouska A, Greiner TC, Lachel CM, Wang C, Dave BJ, Amador CC, Fu K, Vose JM, Weisenburger DD, Gascoyne RD, Hartmann S, Pedersen MB, Wilcox R, ... ... Staudt L, et al. Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways Blood. 128: 4096-4096. DOI: 10.1182/Blood.V128.22.4096.4096 |
0.365 |
|
| 2016 |
Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican TB, Lachel CM, Yu J, Fu K, Ferro RA, Eldorghamy N, Greiner TC, Vose JM, Weisenburger DD, Gascoyne RD, ... ... Staudt LM, et al. Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target Blood. 128: 4095-4095. DOI: 10.1182/Blood.V128.22.4095.4095 |
0.394 |
|
| 2016 |
Gerhard DS, Grande B, Griner N, Casper C, Gerdts SE, Omoding A, Orem J, Mbulaiteye SM, Ogwang MD, Reynolds SJ, Bhatia K, Ayers L, Choi JK, Mullighan CG, Sandlund JT, ... ... Staudt LM, et al. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction Blood. 128: 1760-1760. DOI: 10.1182/Blood.V128.22.1760.1760 |
0.386 |
|
| 2015 |
Rohr J, Guo S, Huo J, Bouska A, Lachel C, Li Y, Simone PD, Zhang W, Gong Q, Wang C, Cannon A, Heavican T, Mottok A, Hung S, Rosenwald A, ... ... Staudt LM, et al. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia. PMID 26719098 DOI: 10.1038/Leu.2015.357 |
0.345 |
|
| 2015 |
Kelly PN, Romero DL, Yang Y, Shaffer AL, Chaudhary D, Robinson S, Miao W, Rui L, Westlin WF, Kapeller R, Staudt LM. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. The Journal of Experimental Medicine. PMID 26621451 DOI: 10.1084/Jem.20151074 |
0.387 |
|
| 2015 |
Young RM, Wu T, Schmitz R, Dawood M, Xiao W, Phelan JD, Xu W, Menard L, Meffre E, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, ... ... Staudt LM, et al. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proceedings of the National Academy of Sciences of the United States of America. 112: 13447-54. PMID 26483459 DOI: 10.1073/Pnas.1514944112 |
0.451 |
|
| 2015 |
Kendrick S, Tus K, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, Fu K, ... Staudt LM, et al. Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status. Leukemia & Lymphoma. 1-4. PMID 26437080 DOI: 10.3109/10428194.2015.1072767 |
0.462 |
|
| 2015 |
Hathcock KS, Padilla-Nash HM, Camps J, Shin DM, Triner D, Shaffer AL, Maul RW, Steinberg SM, Gearhart PJ, Staudt LM, Morse HC, Ried T, Hodes RJ. ATM deficiency in absence of T cells promotes development of NF-kB-dependent murine B cell lymphomas that resemble human ABC DLBCL. Blood. PMID 26400962 DOI: 10.1182/Blood-2015-06-654749 |
0.48 |
|
| 2015 |
Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, ... ... Staudt LM, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood. PMID 26268241 DOI: 10.1182/Blood-2015-05-644591 |
0.426 |
|
| 2015 |
Scott DW, Mottok A, Ennishi D, Wright GW, Farinha P, Ben-Neriah S, Kridel R, Barry GS, Hother C, Abrisqueta P, Boyle M, Meissner B, Telenius A, Savage KJ, Sehn LH, ... ... Staudt LM, et al. Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2848-56. PMID 26240231 DOI: 10.1200/Jco.2014.60.2383 |
0.469 |
|
| 2015 |
Bunin A, Sisirak V, Ghosh HS, Grajkowska LT, Hou ZE, Miron M, Yang C, Ceribelli M, Uetani N, Chaperot L, Plumas J, Hendriks W, Tremblay ML, Häcker H, Staudt LM, et al. Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells. Immunity. PMID 26231120 DOI: 10.1016/J.Immuni.2015.07.009 |
0.325 |
|
| 2015 |
Wilson WH, Young RM, Schmitz R, Yang Y, Pittaluga S, Wright G, Lih CJ, Williams PM, Shaffer AL, Gerecitano J, de Vos S, Goy A, Kenkre VP, Barr PM, Blum KA, ... ... Staudt LM, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nature Medicine. PMID 26193343 DOI: 10.1038/Nm.3884 |
0.459 |
|
| 2015 |
Yuan J, Wright G, Rosenwald A, Steidl C, Gascoyne RD, Connors JM, Mottok A, Weisenburger DD, Greiner TC, Fu K, Smith L, Rimsza LM, Jaffe ES, Campo E, Martinez A, ... ... Staudt LM, et al. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling. The American Journal of Surgical Pathology. PMID 26135560 DOI: 10.1097/Pas.0000000000000473 |
0.372 |
|
| 2015 |
Malecka A, Tierens A, Østlie I, Schmitz R, Trøen G, Spetalen S, Staudt LM, Smeland E, Holte H, Delabie J. Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell. Haematologica. 100: e415-8. PMID 26001788 DOI: 10.3324/Haematol.2015.126656 |
0.41 |
|
| 2015 |
Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Steinberg SM, Chen CC, Zheng J, Willis TD, Faham M, et al. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. The Lancet. Oncology. 16: 541-9. PMID 25842160 DOI: 10.1016/S1470-2045(15)70106-3 |
0.395 |
|
| 2015 |
Weinstock DM, Dalla-Favera R, Gascoyne RD, Leonard JP, Levy R, Lossos IS, Melnick AM, Nowakowski GS, Press OW, Savage KJ, Shipp MA, Staudt LM. A roadmap for discovery and translation in lymphoma. Blood. 125: 2175-7. PMID 25814490 DOI: 10.1182/Blood-2015-01-623777 |
0.358 |
|
| 2015 |
Young RM, Shaffer AL, Phelan JD, Staudt LM. B-cell receptor signaling in diffuse large B-cell lymphoma. Seminars in Hematology. 52: 77-85. PMID 25805587 DOI: 10.1053/J.Seminhematol.2015.01.008 |
0.485 |
|
| 2015 |
Yang Y, Staudt LM. Protein ubiquitination in lymphoid malignancies. Immunological Reviews. 263: 240-56. PMID 25510281 DOI: 10.1111/Imr.12247 |
0.381 |
|
| 2015 |
Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C, Rohr J, Guo S, Smith LM, Wright G, Bhagavathi S, Dybkaer K, ... ... Staudt LM, et al. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood. 125: 1137-45. PMID 25498913 DOI: 10.1182/Blood-2014-04-566778 |
0.42 |
|
| 2015 |
Wang X, Wang H, Bi C, Zhang X, Huang X, Zhang X, Iqbal J, Wright GW, Staudt LM, Chan WC, McKeithan TW, Wang P, Zhang H, Fu K. Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination Blood. 126: 3638-3638. DOI: 10.1182/Blood.V126.23.3638.3638 |
0.338 |
|
| 2015 |
Staudt LM. Abstract IA09: Therapy of lymphoma inspired by functional and structural genomics Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Ia09 |
0.444 |
|
| 2015 |
Nakagawa M, Schmitz R, Xiao W, Goldman CK, Xu W, Yang Y, Yu X, Waldmann TA, Staudt LM. Abstract 3936: Frequent gain-of-function CCR4 mutations in adult T-cell leukemia/lymphoma (ATLL) Cancer Research. 75: 3936-3936. DOI: 10.1158/1538-7445.Am2015-3936 |
0.409 |
|
| 2015 |
Wang X, Wang H, Bi C, Zhang X, Huang X, Zhang X, Iqbal J, Wright G, Staudt L, Chan W, McKeithan T, Wang P, Zhang H, Fu K. 296P miR-17 ∼ 92 activates the canonical NF-&kgr;B signaling by targeting TNFAIP3, CYLD and Rnf11 in ABC-DLBCL lymphoma Annals of Oncology. 26: ix85. DOI: 10.1093/Annonc/Mdv526.12 |
0.322 |
|
| 2014 |
Nakagawa M, Schmitz R, Xiao W, Goldman CK, Xu W, Yang Y, Yu X, Waldmann TA, Staudt LM. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma. The Journal of Experimental Medicine. 211: 2497-505. PMID 25488980 DOI: 10.1084/Jem.20140987 |
0.372 |
|
| 2014 |
Qian J, Wang Q, Dose M, Pruett N, Kieffer-Kwon KR, Resch W, Liang G, Tang Z, Mathé E, Benner C, Dubois W, Nelson S, Vian L, Oliveira TY, Jankovic M, ... ... Staudt L, et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell. 159: 1524-37. PMID 25483777 DOI: 10.1016/J.Cell.2014.11.013 |
0.439 |
|
| 2014 |
Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, An J, Xu Y, Rosenwald A, Ott G, Gascoyne RD, Rimsza LM, Campo E, Jaffe ES, Delabie J, ... ... Staudt LM, et al. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature. 516: 254-8. PMID 25274307 DOI: 10.1038/Nature13765 |
0.324 |
|
| 2014 |
Kendrick SL, Redd L, Muranyi A, Henricksen LA, Stanislaw S, Smith LM, Perry AM, Fu K, Weisenburger DD, Rosenwald A, Ott G, Gascoyne RD, Jaffe ES, Campo E, Delabie J, ... ... Staudt LM, et al. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. Human Pathology. 45: 2144-53. PMID 25090918 DOI: 10.1016/J.Humpath.2014.06.005 |
0.448 |
|
| 2014 |
Ceribelli M, Kelly PN, Shaffer AL, Wright GW, Xiao W, Yang Y, Mathews Griner LA, Guha R, Shinn P, Keller JM, Liu D, Patel PR, Ferrer M, Joshi S, Nerle S, ... ... Staudt LM, et al. Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 111: 11365-70. PMID 25049379 DOI: 10.1073/Pnas.1411701111 |
0.455 |
|
| 2014 |
Wilson WH, Pittaluga S, Nicolae A, Camphausen K, Shovlin M, Steinberg SM, Roschewski M, Staudt LM, Jaffe ES, Dunleavy K. A prospective study of mediastinal gray-zone lymphoma. Blood. 124: 1563-9. PMID 25024303 DOI: 10.1182/Blood-2014-03-564906 |
0.393 |
|
| 2014 |
Ghosh HS, Ceribelli M, Matos I, Lazarovici A, Bussemaker HJ, Lasorella A, Hiebert SW, Liu K, Staudt LM, Reizis B. ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2. The Journal of Experimental Medicine. 211: 1623-35. PMID 24980046 DOI: 10.1084/Jem.20132121 |
0.331 |
|
| 2014 |
Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA, Teh BT, Lim ST, Tan SY, Rimsza LM, Jaffe ES, ... ... Staudt LM, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 123: 2915-23. PMID 24632715 DOI: 10.1182/Blood-2013-11-536359 |
0.455 |
|
| 2014 |
Ippolito GC, Dekker JD, Wang YH, Lee BK, Shaffer AL, Lin J, Wall JK, Lee BS, Staudt LM, Liu YJ, Iyer VR, Tucker HO. Dendritic cell fate is determined by BCL11A. Proceedings of the National Academy of Sciences of the United States of America. 111: E998-1006. PMID 24591644 DOI: 10.1073/Pnas.1319228111 |
0.422 |
|
| 2014 |
Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM. Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harbor Perspectives in Medicine. 4. PMID 24492847 DOI: 10.1101/Cshperspect.A014282 |
0.519 |
|
| 2014 |
Yang Y, Schmitz R, Mitala J, Whiting A, Xiao W, Ceribelli M, Wright GW, Zhao H, Yang Y, Xu W, Rosenwald A, Ott G, Gascoyne RD, Connors JM, Rimsza LM, ... ... Staudt LM, et al. Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. Cancer Discovery. 4: 480-93. PMID 24491438 DOI: 10.1158/2159-8290.Cd-13-0915 |
0.406 |
|
| 2014 |
Mathews Griner LA, Guha R, Shinn P, Young RM, Keller JM, Liu D, Goldlust IS, Yasgar A, McKnight C, Boxer MB, Duveau DY, Jiang JK, Michael S, Mierzwa T, Huang W, ... ... Staudt LM, et al. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 2349-54. PMID 24469833 DOI: 10.1073/Pnas.1311846111 |
0.416 |
|
| 2014 |
Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Smeland EB, Mottok A, Braziel RM, Ott G, Delabie J, ... ... Staudt LM, et al. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood. 123: 1214-7. PMID 24398326 DOI: 10.1182/Blood-2013-11-536433 |
0.477 |
|
| 2014 |
Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nature Reviews. Clinical Oncology. 11: 12-23. PMID 24217204 DOI: 10.1038/Nrclinonc.2013.197 |
0.408 |
|
| 2014 |
Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, ... ... Staudt LM, et al. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood. 123: 1681-90. PMID 24037725 DOI: 10.1182/Blood-2013-05-500595 |
0.301 |
|
| 2014 |
Younes A, Zinzani PL, Sehn LH, Johnson PWM, Gascoyne RD, Ahmadi T, Bellew KM, Vermeulen J, Zhuang SH, Sun S, Staudt LM, Wilson WH. A randomized, double-blind, placebo-controlled phase 3 study of ibrutinib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in subjects with newly diagnosed nongerminal center B-cell subtype of diffuse large B-cell lymphoma (DLBCL). Journal of Clinical Oncology. 32: TPS8615-TPS8615. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps8615 |
0.425 |
|
| 2014 |
Czuczman MS, Davies A, Linton KM, Wagner-Johnston N, Gascoyne RD, Eberhard DA, Salles G, Witzig TE, Zinzani PL, Wright GW, Staudt LM, Repici J, Song D, Manzke O, Lewis ID. A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL Blood. 124: 628-628. DOI: 10.1182/Blood.V124.21.628.628 |
0.302 |
|
| 2014 |
Dunleavy K, Fanale M, LaCasce A, Noy A, Caimi P, Parekh S, Hayslip JW, Jagadeesh D, Lord RS, Lechowicz MJ, Gaur R, Lucas A, Staudt LM, Steinberg SM, Kahl B, et al. Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma Blood. 124: 395-395. DOI: 10.1182/Blood.V124.21.395.395 |
0.348 |
|
| 2014 |
Shirley CM, Chu SH, Yang Y, Wright GW, Staudt LM, Small D. Genetic and Pharmacologic Notch4 Inhibition Synergizes with FLT3 Tyrosine Kinase Inhibition in Vitro to More Effectively Eliminate FLT3/ITD-Positive Leukemia Cells Blood. 124: 3583-3583. DOI: 10.1182/Blood.V124.21.3583.3583 |
0.427 |
|
| 2014 |
Nakagawa M, Schmitz R, Xiao W, Goldman CK, Xu W, Yang Y, Waldmann TA, Staudt LM. A Gain-of-Function CCR4 Mutations in Adult T-Cell Leukemia/Lymphoma (ATLL) Enhance the Chemotactic Abilities and PI3K/AKT Activation Blood. 124: 3566-3566. DOI: 10.1182/Blood.V124.21.3566.3566 |
0.395 |
|
| 2014 |
Scott DW, Wright GW, Williams M, Lih J, Jaffe ES, Rosenwald A, Campo E, Chan W(C, Connors JM, Smeland E, Braziel RM, Ott G, Delabie J, Weisenburger DD, Cook JR, ... ... Staudt LM, et al. Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues Blood. 124: 3016-3016. DOI: 10.1182/Blood.V124.21.3016.3016 |
0.363 |
|
| 2014 |
Rohr J, Guo S, Hu D, Bouska A, Gascoyne RD, Rosenwald A, Simone P, Zhang W, Xiao W, Wang C, Fu K, Greiner TC, Weisenburger DD, Vose JM, Staudt LM, et al. CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression Blood. 124: 1681-1681. DOI: 10.1182/Blood.V124.21.1681.1681 |
0.327 |
|
| 2014 |
Kendrick SL, Tus K, Scott DW, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, ... ... Staudt LM, et al. Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status Blood. 124: 1667-1667. DOI: 10.1182/Blood.V124.21.1667.1667 |
0.373 |
|
| 2014 |
Scott DW, Mottok A, Ennishi D, Wright GW, Farinha P, Ben-Neriah S, Kridel R, Barry GS, Hother CE, Savage KJ, Sehn LH, Staudt LM, Connors JM, Rimsza LM, Gascoyne RD. Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry Blood. 124: 1624-1624. DOI: 10.1182/Blood.V124.21.1624.1624 |
0.406 |
|
| 2014 |
Roschewski M, Dunleavy K, Pittaluga S, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Chen CC, Zheng J, Willis TD, Faham M, Wilson WH. Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma Blood. 124: 139-139. DOI: 10.1182/Blood.V124.21.139.139 |
0.317 |
|
| 2014 |
Kelly PN, Chaudhary D, Young RM, Shaffer A, Robinson S, Romero DL, Kapeller R, Staudt LM. Abstract LB-112: Highly potent and selective interleukin-1 receptor-associated kinase 4 inhibitors for the therapy of lymphoid malignancies Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-112 |
0.375 |
|
| 2013 |
Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G, Delabie J, ... ... Staudt LM, et al. Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4520-8. PMID 24220563 DOI: 10.1200/Jco.2012.45.6004 |
0.418 |
|
| 2013 |
Sawai CM, Sisirak V, Ghosh HS, Hou EZ, Ceribelli M, Staudt LM, Reizis B. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. The Journal of Experimental Medicine. 210: 2151-9. PMID 24101375 DOI: 10.1084/Jem.20130443 |
0.385 |
|
| 2013 |
Enjuanes A, Albero R, Clot G, Navarro A, Beà S, Pinyol M, Martín-Subero JI, Klapper W, Staudt LM, Jaffe ES, Rimsza L, Braziel RM, Delabie J, Cook JR, Tubbs RR, et al. Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features International Journal of Cancer. 133: 2852-2863. PMID 23754783 DOI: 10.1002/Ijc.28321 |
0.37 |
|
| 2013 |
Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. The New England Journal of Medicine. 368: 1408-16. PMID 23574119 DOI: 10.1056/Nejmoa1214561 |
0.408 |
|
| 2013 |
Lamy L, Ngo VN, Emre NC, Shaffer AL, Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O, Staudt LM. Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell. 23: 435-49. PMID 23541952 DOI: 10.1016/J.Ccr.2013.02.017 |
0.768 |
|
| 2013 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, ... ... Staudt LM, et al. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discovery. 3: 564-77. PMID 23471820 DOI: 10.1158/2159-8290.Cd-12-0504 |
0.401 |
|
| 2013 |
Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nature Reviews. Drug Discovery. 12: 229-43. PMID 23449308 DOI: 10.1038/Nrd3937 |
0.417 |
|
| 2013 |
Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, ... ... Staudt LM, et al. Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 110: 3943-8. PMID 23431138 DOI: 10.1073/Pnas.1217271110 |
0.382 |
|
| 2013 |
Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, Casellas R, Robbiani DF, Staudt L, Fernandez-Capetillo O, Nussenzweig A. Identification of early replicating fragile sites that contribute to genome instability. Cell. 152: 620-32. PMID 23352430 DOI: 10.1016/J.Cell.2013.01.006 |
0.349 |
|
| 2013 |
Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ. Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene. 32: 5429-38. PMID 23318429 DOI: 10.1038/Onc.2012.590 |
0.351 |
|
| 2013 |
Lim KH, Staudt LM. Toll-like receptor signaling. Cold Spring Harbor Perspectives in Biology. 5: a011247. PMID 23284045 DOI: 10.1101/Cshperspect.A011247 |
0.309 |
|
| 2013 |
Kucuk C, Jiang B, Hu X, Gaulard P, Zhang W, Xiao W, Staudt LM, Iqbal J, Zhang W, Cornish A, Kavak P, Alkan C, Gong Q, Yang Q, Sun H, et al. Frequent Activating Mutations Of JAK-STAT Pathway Genes In Natural Killer Cell Lymphomas Blood. 122: 812-812. DOI: 10.1182/Blood.V122.21.812.812 |
0.423 |
|
| 2013 |
Scott DW, Wright GW, Williams M, Lih J, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Smeland EB, Mottok A, Braziel RM, Ott G, Delabie J, ... ... Staudt LM, et al. Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project Blood. 122: 73-73. DOI: 10.1182/Blood.V122.21.73.73 |
0.428 |
|
| 2013 |
Dunleavy K, Pittaluga S, Shovlin M, Pack S, Steinberg SM, Lai CE, Grant C, Hsi ED, Staudt LM, Jaffe ES, Wilson WH. Concurrent Expression Of MYC/BCL2 Protein In Newly Diagnosed DLBCL Is Not Associated With An Inferior Survival Following EPOCH-R Therapy Blood. 122: 3029-3029. DOI: 10.1182/Blood.V122.21.3029.3029 |
0.393 |
|
| 2013 |
Roschewski M, Pittaluga S, Dunleavy K, Kong K, Shovlin M, Jaffe ES, Staudt LM, Zheng J, Willis T, Faham M, Wilson WH. DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma Blood. 122: 1767-1767. DOI: 10.1182/Blood.V122.21.1767.1767 |
0.313 |
|
| 2013 |
Mathews LA, Guha R, Shinn P, Young RM, Lim K, Keller J, Liu D, Yasgar A, McKnight C, Boxer MB, Duveau DY, Jiang J, Michael S, Mott BT, Patel PR, ... ... Staudt L, et al. Abstract 4543: High-throughput combination screening identifies novel drug-drug pairings for a Bruton's tyrosine kinase inhibitor against the ABC subtype of diffuse large B-cell lymphomas. Cancer Research. 73: 4543-4543. DOI: 10.1158/1538-7445.Am2013-4543 |
0.382 |
|
| 2013 |
Kim MKH, Wright G, Staudt L, Annunziata C. Abstract 3144: shRNA library screening by dual shRNA technique identifies CHEK1 as a synthetic lethal gene in the absence of IKKε in ovarian cancer. Cancer Research. 73: 3144-3144. DOI: 10.1158/1538-7445.Am2013-3144 |
0.374 |
|
| 2013 |
Lim K, Barton GM, Staudt LM. Abstract 2332: OncogenicMYD88mutants require Toll-like receptors. Cancer Research. 73: 2332-2332. DOI: 10.1158/1538-7445.Am2013-2332 |
0.377 |
|
| 2012 |
Young RM, Staudt LM. A new "brew" of MALT1 inhibitors. Cancer Cell. 22: 706-7. PMID 23238011 DOI: 10.1016/J.Ccr.2012.11.011 |
0.455 |
|
| 2012 |
Snow AL, Xiao W, Stinson JR, Lu W, Benjamin CD, Zheng L, Pittaluga S, Matthews HF, Schmitz R, Jhavar S, Kuchen S, Kardava L, Wang W, Lamborn IT, Jing H, ... ... Staudt LM, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations Journal of Experimental Medicine. 209: 2247-2261. PMID 23129749 DOI: 10.1084/Jem.20120831 |
0.46 |
|
| 2012 |
Shaffer AL, Staudt LM. The case of the missing c-Myc. Nature Immunology. 13: 1029-31. PMID 23080195 DOI: 10.1038/Ni.2455 |
0.431 |
|
| 2012 |
Wan X, Yeung C, Kim SY, Dolan JG, Ngo VN, Burkett S, Khan J, Staudt LM, Helman LJ. Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. Cancer Research. 72: 5889-99. PMID 23002205 DOI: 10.1158/0008-5472.Can-12-1991 |
0.35 |
|
| 2012 |
Sanda T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A, Ma W, Tatarek J, Ahn Y, Kelliher MA, Jamieson CH, Staudt LM, Young RA, Look AT. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell. 22: 209-21. PMID 22897851 DOI: 10.1016/J.Ccr.2012.06.007 |
0.357 |
|
| 2012 |
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, ... ... Staudt LM, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 490: 116-20. PMID 22885699 DOI: 10.1038/Nature11378 |
0.501 |
|
| 2012 |
Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, ... ... Staudt LM, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3452-9. PMID 22851565 DOI: 10.1200/Jco.2011.41.0985 |
0.445 |
|
| 2012 |
Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, ... ... Staudt LM, et al. A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. Blood. 120: 2290-6. PMID 22740447 DOI: 10.1182/Blood-2012-05-430389 |
0.408 |
|
| 2012 |
Huang X, Di Liberto M, Jayabalan D, Liang J, Ely S, Bretz J, Shaffer AL, Louie T, Chen I, Randolph S, Hahn WC, Staudt LM, Niesvizky R, Moore MA, Chen-Kiang S. Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. Blood. 120: 1095-106. PMID 22718837 DOI: 10.1182/Blood-2012-03-415984 |
0.381 |
|
| 2012 |
Yang Y, Shaffer AL, Emre NC, Ceribelli M, Zhang M, Wright G, Xiao W, Powell J, Platig J, Kohlhammer H, Young RM, Zhao H, Yang Y, Xu W, Buggy JJ, ... ... Staudt LM, et al. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell. 21: 723-37. PMID 22698399 DOI: 10.1016/J.Ccr.2012.05.024 |
0.811 |
|
| 2012 |
Kentsis A, Reed C, Rice KL, Sanda T, Rodig SJ, Tholouli E, Christie A, Valk PJ, Delwel R, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Byers RJ, Christensen JG, ... ... Staudt LM, et al. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nature Medicine. 18: 1118-22. PMID 22683780 DOI: 10.1038/Nm.2819 |
0.402 |
|
| 2012 |
Chen E, Staudt LM, Green AR. Janus kinase deregulation in leukemia and lymphoma. Immunity. 36: 529-41. PMID 22520846 DOI: 10.1016/J.Immuni.2012.03.017 |
0.329 |
|
| 2012 |
Lim KH, Yang Y, Staudt LM. Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunological Reviews. 246: 359-78. PMID 22435566 DOI: 10.1111/J.1600-065X.2012.01105.X |
0.366 |
|
| 2012 |
Deffenbacher KE, Iqbal J, Sanger W, Shen Y, Lachel C, Liu Z, Liu Y, Lim MS, Perkins SL, Fu K, Smith L, Lynch J, Staudt LM, Rimsza LM, Jaffe E, et al. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood. 119: 3757-66. PMID 22374697 DOI: 10.1182/Blood-2011-05-349662 |
0.436 |
|
| 2012 |
Shaffer AL, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annual Review of Immunology. 30: 565-610. PMID 22224767 DOI: 10.1146/Annurev-Immunol-020711-075027 |
0.504 |
|
| 2012 |
Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, Chan WC, Fu K. The miRNA-17 ∼ 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation Leukemia. 26: 1064-1072. PMID 22116552 DOI: 10.1038/Leu.2011.305 |
0.319 |
|
| 2012 |
Staudt LM. Chronic Active B-Cell Receptor Signaling in Lymphoma Blood. 120: SCI-26-SCI-26. DOI: 10.1182/Blood.V120.21.Sci-26.Sci-26 |
0.454 |
|
| 2012 |
Wilson WH, Gerecitano JF, Goy A, de Vos S, Kenkre VP, Barr PM, Blum KA, Shustov AR, Advani RH, Lih J, Williams M, Schmitz R, Yang Y, Pittaluga S, Wright G, ... ... Staudt LM, et al. The Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), Has Preferential Activity in the ABC Subtype of Relapsed/Refractory De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results of a Multicenter, Open-Label, Phase 2 Study Blood. 120: 686-686. DOI: 10.1182/Blood.V120.21.686.686 |
0.423 |
|
| 2012 |
Lim K, Romero DL, Chaudhary D, Robinson SD, Staudt LM. IRAK4 Kinase As A Novel Therapeutic Target in the ABC Subtype of Diffuse Large B Cell Lymphoma Blood. 120: 62-62. DOI: 10.1182/Blood.V120.21.62.62 |
0.439 |
|
| 2012 |
Böodöor C, Vera G, Kohlmann A, Tan K, Okosun J, Popov N, Araf S, Marzec J, O‘Riain C, Lee A, Clear AJ, Montoto S, Matthews J, Iqbal S, Rajnai H, ... ... Staudt LM, et al. High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy Blood. 120: 545-545. DOI: 10.1182/Blood.V120.21.545.545 |
0.304 |
|
| 2012 |
Bouska A, McKeithan T, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Liu Z, Kucuk C, Bertoni F, Rinaldi A, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, ... ... Staudt LM, et al. Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma. Blood. 120: 2648-2648. DOI: 10.1182/Blood.V120.21.2648.2648 |
0.359 |
|
| 2012 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover JM, Chang BH, Yost AJ, Weng AP, Ma W, Tatarek J, Fleischman AG, Ahn Y, Yang Y, Zhou W, Neuberg DS, ... ... Staudt LM, et al. TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia Blood. 120: 1470-1470. DOI: 10.1182/Blood.V120.21.1470.1470 |
0.426 |
|
| 2012 |
Staudt LM. Abstract IA19: New therapeutic strategies for lymphomas inspired by functional and structural genomics Cancer Research. 72: IA19-IA19. DOI: 10.1158/1538-7445.Nonrna12-Ia19 |
0.347 |
|
| 2011 |
Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, et al. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood. 118: 5550-8. PMID 21960592 DOI: 10.1182/Blood-2011-06-361972 |
0.348 |
|
| 2011 |
Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, et al. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7785-95. PMID 21933893 DOI: 10.1158/1078-0432.Ccr-11-0267 |
0.458 |
|
| 2011 |
Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, ... ... Staudt LM, et al. Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. International Journal of Molecular Epidemiology and Genetics. 2: 245-52. PMID 21915363 |
0.33 |
|
| 2011 |
Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, ... ... Staudt L, et al. High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica. 96: 996-1001. PMID 21546504 DOI: 10.3324/Haematol.2010.037408 |
0.44 |
|
| 2011 |
Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S, Meltzer PS, Staudt LM, Emmert-Buck MR, Jaffe ES. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica. 96: 558-66. PMID 21454882 DOI: 10.1182/Blood.V116.21.747.747 |
0.417 |
|
| 2011 |
Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB, McPherson A, Meissner B, Okoye UC, Diepstra A, van den Berg A, ... ... Staudt LM, et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature. 471: 377-81. PMID 21368758 DOI: 10.1038/Nature09754 |
0.488 |
|
| 2011 |
Rimsza LM, Wright G, Schwartz M, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Cook JR, Tubbs RR, Braziel RM, Delabie J, Miller TP, Staudt LM. Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues Clinical Cancer Research. 17: 3727-3732. PMID 21364035 DOI: 10.1158/1078-0432.Ccr-10-2573 |
0.448 |
|
| 2011 |
Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, ... ... Staudt LM, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 470: 115-9. PMID 21179087 DOI: 10.1038/Nature09671 |
0.415 |
|
| 2011 |
Meyer PN, Fu K, Greiner T, Smith L, Delabie J, Gascoyne R, Ott G, Rosenwald A, Braziel R, Campo E, Vose J, Lenz G, Staudt L, Chan W, Weisenburger DD. The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. American Journal of Clinical Pathology. 135: 54-61. PMID 21173124 DOI: 10.1309/Ajcpjx4Bjv9Nlqhy |
0.44 |
|
| 2011 |
Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT, Hurt EM, Shaffer AL, Kuehl WM, Staudt LM. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood. 117: 2396-404. PMID 21163924 DOI: 10.1182/Blood-2010-04-278788 |
0.401 |
|
| 2011 |
Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, Vose JM, Lenz G, Staudt LM, Chan WC, Weisenburger DD. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 200-7. PMID 21135273 DOI: 10.1200/Jco.2010.30.0368 |
0.413 |
|
| 2011 |
Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 117: 211-20. PMID 20974671 DOI: 10.1182/Blood-2010-07-298349 |
0.355 |
|
| 2011 |
Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, ... ... Staudt LM, et al. Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood. 117: 542-52. PMID 20956803 DOI: 10.1182/Blood-2010-02-269514 |
0.396 |
|
| 2011 |
Schmitz R, Jhavar S, Xiao W, Liu X, Powell J, Wright GW, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Staudt LM. Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas Blood. 118: 435-435. DOI: 10.1182/Blood.V118.21.435.435 |
0.468 |
|
| 2011 |
Staudt LM, Dunleavy K, Buggy JJ, Hedrick E, Lucas N, Pittaluga S, Jhavar S, Schmitz R, Williams M, Lih J, Jaffe ES, Wilson WH. The Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 Modulates Chronic Active BCR Signaling and Induces Tumor Regression in Relapsed/Refractory ABC DLBCL Blood. 118: 2716-2716. DOI: 10.1182/Blood.V118.21.2716.2716 |
0.402 |
|
| 2011 |
Kentsis A, Sanda T, Reed C, Rodig SJ, Tholouli E, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Vande Woude G, Christensen J, Byers R, Kung AL, Staudt LM, Look T. Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition Blood. 118: 1405-1405. DOI: 10.1182/Blood.V118.21.1405.1405 |
0.379 |
|
| 2011 |
Emre NCT, Shaffer AL, Wright GW, Kohlhammer H, Staudt LM. Abstract LB-248: IRF4 as a critical regulator and potential therapeutic target in ABC type diffuse large B-cell lymphoma Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-248 |
0.515 |
|
| 2011 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Moriggl R, Ahn Y, Glover J, Chang BH, Willis SG, Zhou W, Gray NS, Staudt LM, Druker BJ, Look AT. Abstract 2809: Pathway dependence on the tyrosine kinase TYK2 in T-cell acute lymphoblastic leukemia Cancer Research. 71: 2809-2809. DOI: 10.1158/1538-7445.Am2011-2809 |
0.403 |
|
| 2010 |
Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, ... ... Staudt LM, et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell. 18: 590-605. PMID 21156283 DOI: 10.1016/J.Ccr.2010.11.013 |
0.786 |
|
| 2010 |
Wang Y, Ngo VN, Marani M, Yang Y, Wright G, Staudt LM, Downward J. Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene. 29: 4658-70. PMID 20562906 DOI: 10.1038/Onc.2010.218 |
0.358 |
|
| 2010 |
Milhollen MA, Traore T, Adams-Duffy J, Thomas MP, Berger AJ, Dang L, Dick LR, Garnsey JJ, Koenig E, Langston SP, Manfredi M, Narayanan U, Rolfe M, Staudt LM, Soucy TA, et al. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood. 116: 1515-23. PMID 20525923 DOI: 10.1182/Blood-2010-03-272567 |
0.449 |
|
| 2010 |
Staudt LM. Oncogenic activation of NF-kappaB. Cold Spring Harbor Perspectives in Biology. 2: a000109. PMID 20516126 DOI: 10.1101/Cshperspect.A000109 |
0.404 |
|
| 2010 |
Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, ... ... Staudt LM, et al. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood. 116: 953-61. PMID 20421449 DOI: 10.1182/Blood-2010-01-263806 |
0.424 |
|
| 2010 |
Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, ... ... Staudt LM, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma New England Journal of Medicine. 362: 875-885. PMID 20220182 DOI: 10.1056/Nejmoa0905680 |
0.355 |
|
| 2010 |
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, ... ... Staudt LM, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 463: 88-92. PMID 20054396 DOI: 10.1038/Nature08638 |
0.47 |
|
| 2010 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Moriggl R, Ahn Y, Glover JM, Chang BH, Willis SG, Staudt LM, Druker BJ, Look AT. Pathway Dependence on the Tyrosine Kinase TYK2 and Its Mediator STAT1 In T-Cell Acute Lymphoblastic Leukemia Blood. 116: 3155-3155. DOI: 10.1182/Blood.V116.21.3155.3155 |
0.402 |
|
| 2010 |
Johnson NA, Connors JM, Ben-Neriah S, Rogic S, Savage KJ, Steidl C, Horsman DE, Slack GW, Sehn L, Chan W, Iqbal J, Meyer PN, Lenz G, Wright GW, Rimsza LM, ... ... Staudt LM, et al. Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP Blood. 116: 2005-2005. DOI: 10.1182/Blood.V116.21.2005.2005 |
0.412 |
|
| 2010 |
Kentsis A, Sanda T, Ngo V, Rodig SJ, Kutok J, Tholouli E, Byers R, Woude GV, Kung AL, Staudt LM, Look AT. Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia. Blood. 116: 1042-1042. DOI: 10.1182/Blood.V116.21.1042.1042 |
0.429 |
|
| 2010 |
Ranuncolo SM, Ngo V, Xiao W, Wright G, Staudt LM. Abstract 3898: Octamer Binding Protein-2 (Oct-2): A non-oncogene addiction in germinal center derived lymphomas and a promising therapeutic target Cancer Research. 70: 3898-3898. DOI: 10.1158/1538-7445.Am10-3898 |
0.508 |
|
| 2009 |
Hailfinger S, Lenz G, Ngo V, Posvitz-Fejfar A, Rebeaud F, Guzzardi M, Penas EM, Dierlamm J, Chan WC, Staudt LM, Thome M. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 19946-51. PMID 19897720 DOI: 10.1073/Pnas.0907511106 |
0.446 |
|
| 2009 |
Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, ... ... Staudt LM, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 94: 1555-62. PMID 19880778 DOI: 10.3324/Haematol.2009.010264 |
0.466 |
|
| 2009 |
Wilkinson ST, Fernandez DR, Murphy SP, Braziel RM, Campo E, Chan WC, Delabie J, Gascoyne RD, Staudt LM, Jaffe ES, Rosenwald A, Rimsza LM. Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. Leukemia & Lymphoma. 50: 1875-8. PMID 19814686 DOI: 10.3109/10428190903297531 |
0.399 |
|
| 2009 |
Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, ... ... Staudt LM, et al. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. The Journal of Clinical Investigation. 119: 3395-407. PMID 19809159 DOI: 10.1172/Jci39703 |
0.393 |
|
| 2009 |
Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, ... ... Staudt LM, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5494-502. PMID 19706817 DOI: 10.1158/1078-0432.Ccr-09-0113 |
0.441 |
|
| 2009 |
O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein CA, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, ... ... Staudt LM, et al. Array-based DNA methylation profiling in follicular lymphoma. Leukemia. 23: 1858-66. PMID 19587707 DOI: 10.1038/Leu.2009.114 |
0.347 |
|
| 2009 |
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, ... Staudt LM, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood. 114: 826-34. PMID 19471018 DOI: 10.1182/Blood-2009-01-198580 |
0.372 |
|
| 2009 |
Shaffer AL, Emre NC, Romesser PB, Staudt LM. IRF4: Immunity. Malignancy! Therapy? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2954-61. PMID 19383829 DOI: 10.1158/1078-0432.Ccr-08-1845 |
0.806 |
|
| 2009 |
Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood. 113: 6069-76. PMID 19380866 DOI: 10.1182/Blood-2009-01-199679 |
0.466 |
|
| 2009 |
Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J. c-Myc and Rel/NF-κB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells Journal of Virology. 83: 5014-5027. PMID 19264782 DOI: 10.1128/Jvi.02264-08 |
0.446 |
|
| 2009 |
Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP. CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression. Haematologica. 94: 596-8. PMID 19229048 DOI: 10.3324/Haematol.2008.000752 |
0.456 |
|
| 2009 |
Bidère N, Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Vazquez A, Sakai K, Zhang J, Meng Z, Veenstra TD, ... Staudt LM, et al. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 458: 92-6. PMID 19118383 DOI: 10.1038/Nature07613 |
0.424 |
|
| 2009 |
Meragelman TL, Scudiero DA, Davis RE, Staudt LM, McCloud TG, Cardellina JH, Shoemaker RH. Inhibitors of the NF-κB activation pathway from cryptocarya rugulosa Journal of Natural Products. 72: 336-339. PMID 19093800 DOI: 10.1021/Np800350X |
0.357 |
|
| 2009 |
Martinez-Garcia E, Popovic R, Min D, Will C, Meyer J, Staudt LM, Lamy L, Lauring J, Cheng Z, Patel D, Licht JD. The MMSET Histone Methyl Transferase Alters Chromatin Structure and Gene Expression in t(4;14) Multiple Myeloma Cells. Blood. 114: 675-675. DOI: 10.1182/Blood.V114.22.675.675 |
0.423 |
|
| 2009 |
Rimsza LM, Wright G, Schwartz M, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Cook JR, Tubbs RR, Braziel RM, Delabie J, Miller TP, Fisher RI, ... Staudt LM, et al. Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project. Blood. 114: 620-620. DOI: 10.1182/Blood.V114.22.620.620 |
0.417 |
|
| 2009 |
Ranuncolo SM, Ngo V, Lenz G, Xiao W, Wright G, Staudt LM. OCT2 (Octamer Binding Protein 2): An Essential Role in Germinal Center B Cell Differentiation and the “Achilles Heel” of Derived Lymphomas. Blood. 114: 362-362. DOI: 10.1182/Blood.V114.22.362.362 |
0.511 |
|
| 2009 |
Deffenbacher KE, Iqbal J, Liu Z, Perkins SL, Lim MS, Fu K, Shen Y, Staudt LM, Rimsza LM, Jaffe ES, Rosenwald A, Ott G, Delabie J, Campo E, Gascoyne RD, et al. Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL). Blood. 114: 2922-2922. DOI: 10.1182/Blood.V114.22.2922.2922 |
0.45 |
|
| 2009 |
Perez Galan P, Jensen HM, Weniger MA, Chapman CM, Liu P, Raghavachari N, Shaffer AL, Staudt LM, Wiestner A. Bortezomib Resistance in Mantle Cell Lymphoma Is Associated with Expression of a Plasmacytoid Differentiation Program. Blood. 114: 287-287. DOI: 10.1182/Blood.V114.22.287.287 |
0.425 |
|
| 2009 |
Cardesa-Salzmann TM, Colomo L, Climent F, Gonzalez-Barca E, López-Guillermo A, Gutierrez G, Mercadal S, Gascoyne RD, Connors JM, Rimsza LM, Braziel RM, Cook JR, Tubbs RR, Rosenwald A, Ott G, ... ... Staudt LM, et al. High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT). Blood. 114: 1948-1948. DOI: 10.1182/Blood.V114.22.1948.1948 |
0.407 |
|
| 2009 |
Johnson NA, Ben-Neriah S, Savage KJ, Lee T, Horsman DE, Connors JM, Chan WC, Lenz G, Wright G, Rimsza LM, Braziel RM, Cook JR, Tubbs RR, Weisenburger DD, Campo E, ... ... Staudt LM, et al. MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL. Blood. 114: 1100-1100. DOI: 10.1182/Blood.V114.22.1100.1100 |
0.444 |
|
| 2009 |
Dunleavy K, Pittaluga S, Tay K, Grant N, Chen CC, Shovlin M, Steinberg S, Staudt LM, Jaffe ES, Janik JE, Wilson WH. Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL). Blood. 114: 106-106. DOI: 10.1182/Blood.V114.22.106.106 |
0.359 |
|
| 2009 |
Kuehl W, Demchenko Y, Glebov O, Zingone A, Staudt L, Brents L, Weiss B, Barlogie B, Shaughnessy J, Bergsagel P. B557 Molecular Pathogenesis of MGUS and Multiple Myeloma Clinical Lymphoma and Myeloma. 9: S149. DOI: 10.1016/S1557-9190(11)70771-5 |
0.343 |
|
| 2008 |
Lam LT, Davis RE, Ngo VN, Lenz G, Wright G, Xu W, Zhao H, Yu X, Dang L, Staudt LM. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen. Proceedings of the National Academy of Sciences of the United States of America. 105: 20798-803. PMID 19104039 DOI: 10.1073/Pnas.0806491106 |
0.419 |
|
| 2008 |
Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, ... ... Staudt LM, et al. Stromal gene signatures in large-B-cell lymphomas. The New England Journal of Medicine. 359: 2313-23. PMID 19038878 DOI: 10.1056/Nejmoa0802885 |
0.472 |
|
| 2008 |
Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, ... ... Staudt LM, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proceedings of the National Academy of Sciences of the United States of America. 105: 13520-5. PMID 18765795 DOI: 10.1073/Pnas.0804295105 |
0.823 |
|
| 2008 |
Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, ... ... Staudt LM, et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica. 93: 1327-34. PMID 18698080 DOI: 10.3324/Haematol.13071 |
0.439 |
|
| 2008 |
O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, ... ... Staudt LM, et al. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood. 112: 3126-9. PMID 18628487 DOI: 10.1182/Blood-2008-05-154013 |
0.358 |
|
| 2008 |
Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, Zeng Y, Chen B, Epstein J, Staudt LM. IRF4 addiction in multiple myeloma. Nature. 454: 226-31. PMID 18568025 DOI: 10.1038/Nature07064 |
0.813 |
|
| 2008 |
Young KH, Leroy K, Møller MB, Colleoni GW, Sánchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, ... ... Staudt LM, et al. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood. 112: 3088-98. PMID 18559976 DOI: 10.1182/Blood-2008-01-129783 |
0.368 |
|
| 2008 |
McKean D, Huppi K, Bell M, Staudt L, Gerhard W, Weigert M. Pillars article: Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA, 81: 3180-3184, May 1984 Journal of Immunology (Baltimore, Md. : 1950). 180: 5765-5769. PMID 18424692 |
0.525 |
|
| 2008 |
Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM, Raffeld M, Gutierrez M, Chabner BA, Staudt L, Jaffe ES, Janik JE. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2717-24. PMID 18378569 DOI: 10.1200/Jco.2007.13.1391 |
0.419 |
|
| 2008 |
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, ... ... Staudt LM, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (New York, N.Y.). 319: 1676-9. PMID 18323416 DOI: 10.1126/Science.1153629 |
0.478 |
|
| 2008 |
Baskar S, Kwong KY, Hofer T, Levy JM, Kennedy MG, Lee E, Staudt LM, Wilson WH, Wiestner A, Rader C. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 396-404. PMID 18223214 DOI: 10.1158/1078-0432.Ccr-07-1823 |
0.457 |
|
| 2008 |
Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, Chan JW, Rosenwald A, Gascoyne RD, Staudt LM. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood. 111: 3701-13. PMID 18160665 DOI: 10.1182/Blood-2007-09-111948 |
0.401 |
|
| 2008 |
Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, ... ... Staudt LM, et al. Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation. Bioorganic & Medicinal Chemistry Letters. 18: 329-35. PMID 18024113 DOI: 10.1016/J.Bmcl.2007.10.100 |
0.308 |
|
| 2008 |
Steidl C, Lee T, Shah SP, Han G, Nayar T, Delaney A, Jones S, Chan WC, Rosenwald A, Rimsza LM, Campo E, Jaffe ES, Staudt LM, Lenz G, Connors JM, et al. Genome-Wide Expression Profiling Predicts Treatment Outcome in Classical Hodgkin Lymphoma Blood. 112: 520-520. DOI: 10.1182/Blood.V112.11.520.520 |
0.43 |
|
| 2008 |
Lenz G, Wright G, Dave S, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast MA, Fu K, Weisenburger DD, Greiner TC, ... ... Staudt LM, et al. Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma Blood. 112: 475-475. DOI: 10.1182/BLOOD.V112.11.475.475 |
0.343 |
|
| 2008 |
Rao E, McKeithan T, Jiang C, Ji M, Iqbal J, Wright G, Staudt LM, Zhao Y, Chan WC, Fu K. The Mir-17~92 Cluster Enhances Cell Growth and Resistance to Chemotherapy in Mantle Cell Lymphoma by Down-Regulating PTEN, PHLPP2 and BIM Blood. 112: 373-373. DOI: 10.1182/Blood.V112.11.373.373 |
0.313 |
|
| 2008 |
Deffenbacher KE, Wright G, Iqbal J, Geng H, O’Shea D, Lister TA, Fitzgibbon J, Fu K, Liu Z, Weisenburger D, Greiner TC, Gascoyne RD, Rosenwald A, Campo E, Rimsza LM, ... ... Staudt LM, et al. Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma. Blood. 112: 2049-2049. DOI: 10.1182/Blood.V112.11.2049.2049 |
0.341 |
|
| 2008 |
Wilkinson ST, Fernandez DR, Murphy SP, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Rimsza LM. Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV. Blood. 112: 1786-1786. DOI: 10.1182/Blood.V112.11.1786.1786 |
0.368 |
|
| 2008 |
Lam LT, Davis RE, Ngo V, Wright G, Lenz G, Zhao H, Yu X, Dang L, Staudt LM. Abstract LB-239: An rnai sensitization screen identifies compensatory IKKα activation during IKKβ inhibition Cancer Research. 68. DOI: 10.1158/1538-7445.Am2008-Lb-239 |
0.444 |
|
| 2007 |
Wan F, Anderson DE, Barnitz RA, Snow A, Bidere N, Zheng L, Hegde V, Lam LT, Staudt LM, Levens D, Deutsch WA, Lenardo MJ. Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. Cell. 131: 927-39. PMID 18045535 DOI: 10.1016/J.Cell.2007.10.009 |
0.356 |
|
| 2007 |
Young KH, Weisenburger DD, Dave BJ, Smith L, Sanger W, Iqbal J, Campo E, Delabie J, Gascoyne RD, Ott G, Rimsza L, Müller-Hermelink HK, Jaffe ES, Rosenwald A, Staudt LM, et al. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Blood. 110: 4396-405. PMID 17881637 DOI: 10.1182/Blood-2007-02-072082 |
0.386 |
|
| 2007 |
Kimm LR, deLeeuw RJ, Savage KJ, Rosenwald A, Campo E, Delabie J, Ott G, Muller-Hermelink HK, Jaffe ES, Rimsza LM, Weisenburger DD, Chan WC, Staudt LM, Connors JM, Gascoyne RD, et al. Frequent occurrence of deletions in primary mediastinal B-cell lymphoma. Genes, Chromosomes & Cancer. 46: 1090-7. PMID 17823928 DOI: 10.1002/Gcc.20495 |
0.34 |
|
| 2007 |
Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB. Characterization of early stages of human B cell development by gene expression profiling. Journal of Immunology (Baltimore, Md. : 1950). 179: 3662-71. PMID 17785802 DOI: 10.4049/Jimmunol.179.6.3662 |
0.475 |
|
| 2007 |
Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, ... ... Staudt LM, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 12: 115-30. PMID 17692804 DOI: 10.1016/J.Ccr.2007.07.004 |
0.391 |
|
| 2007 |
Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, ... ... Staudt LM, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 21: 2332-43. PMID 17625604 DOI: 10.1038/Sj.Leu.2404856 |
0.478 |
|
| 2007 |
Dunleavy K, Staudt LM, Wilson WH. The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma. Leukemia & Lymphoma. 48: 1061-3. PMID 17577765 DOI: 10.1080/10428190701420467 |
0.403 |
|
| 2007 |
Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, Rodríguez J, Zajac M, Benitez J, Staudt LM, Martinez-Delgado B. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3321-9. PMID 17577022 DOI: 10.1200/Jco.2006.09.4474 |
0.454 |
|
| 2007 |
Kuo TC, Shaffer AL, Haddad J, Choi YS, Staudt LM, Calame K. Repression of BCL-6 is required for the formation of human memory B cells in vitro. The Journal of Experimental Medicine. 204: 819-30. PMID 17403935 DOI: 10.1084/Jem.20062104 |
0.431 |
|
| 2007 |
Davis RE, Zhang YQ, Southall N, Staudt LM, Austin CP, Inglese J, Auld DS. A cell-based assay for IkappaBalpha stabilization using a two-color dual luciferase-based sensor. Assay and Drug Development Technologies. 5: 85-103. PMID 17355202 DOI: 10.1089/Adt.2006.048 |
0.41 |
|
| 2007 |
Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, ... ... Staudt LM, et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. The Journal of Experimental Medicine. 204: 633-43. PMID 17353367 DOI: 10.1182/Blood.V108.11.356.356 |
0.45 |
|
| 2007 |
Staudt LM. A closer look at follicular lymphoma. The New England Journal of Medicine. 356: 741-2. PMID 17301308 DOI: 10.1056/Nejmcibr067155 |
0.365 |
|
| 2007 |
Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, ... ... Staudt LM, et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood. 109: 4599-606. PMID 17299095 DOI: 10.1182/Blood-2006-08-039859 |
0.34 |
|
| 2007 |
Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, ... ... Staudt LM, et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 1216-22. PMID 17296973 DOI: 10.1200/Jco.2006.08.4251 |
0.382 |
|
| 2007 |
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, ... ... Staudt LM, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. British Journal of Haematology. 136: 286-93. PMID 17278262 DOI: 10.1111/j.1365-2141.2006.06439.x |
0.336 |
|
| 2007 |
Schlee M, Hölzel M, Bernard S, Mailhammer R, Schuhmacher M, Reschke J, Eick D, Marinkovic D, Wirth T, Rosenwald A, Staudt LM, Eilers M, Baran-Marszak F, Fagard R, Feuillard J, et al. c-MYC activation impairs the NF-κB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma International Journal of Cancer. 120: 1387-1395. PMID 17211884 DOI: 10.1002/Ijc.22372 |
0.441 |
|
| 2007 |
Dunleavy K, Davis RE, Landgren O, Staudt LM, Wilson WH. BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we? Blood. 109: 843-4; discussion 84. PMID 17210865 DOI: 10.1182/Blood-2006-07-038000 |
0.413 |
|
| 2007 |
Lenz G, Davis RE, Ngo VN, Lam LT, George T, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Muller-Hermelink H, Gascoyne RD, Connors JM, Campo E, Jaffe ES, ... ... Staudt LM, et al. CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma. Blood. 110: 692-692. DOI: 10.1182/Blood.V110.11.692.692 |
0.469 |
|
| 2007 |
Lenz G, Wright G, Dave S, Kohlmann A, Xiao W, Powell J, Zhao H, Xu W, Gascoyne RD, Connors JM, May L, Weisenburger DD, Greiner T, Vose J, Armitage JO, ... ... Staudt LM, et al. Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy. Blood. 110: 348-348. DOI: 10.1182/Blood.V110.11.348.348 |
0.432 |
|
| 2007 |
Lenz G, Wright GW, Dave S, Xiao W, Powell J, Rosenwald A, Muller-Hermelink H, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza L, Fisher RI, ... ... Staudt LM, et al. Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH. Blood. 110: 2631-2631. DOI: 10.1182/Blood.V110.11.2631.2631 |
0.491 |
|
| 2006 |
Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V, Beltran E, Agirre X, Marugan I, Marín M, Rosenwald A, Sugimoto KJ, Wheat LM, Karran EL, García JF, ... ... Staudt LM, et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood. 109: 271-80. PMID 16960149 DOI: 10.1182/Blood-2006-06-026500 |
0.511 |
|
| 2006 |
Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 25: 225-36. PMID 16919487 DOI: 10.1016/J.Immuni.2006.07.009 |
0.611 |
|
| 2006 |
Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, ... ... Staudt LM, et al. Molecular diagnosis of Burkitt's lymphoma. The New England Journal of Medicine. 354: 2431-42. PMID 16760443 DOI: 10.1056/Nejmoa055759 |
0.433 |
|
| 2006 |
Liu H, Ippolito GC, Wall JK, Niu T, Probst L, Lee BS, Pulford K, Banham AH, Stockwin L, Shaffer AL, Staudt LM, Das C, Dyer MJ, Tucker PW. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Molecular Cancer. 5: 18. PMID 16704730 DOI: 10.1186/1476-4598-5-18 |
0.476 |
|
| 2006 |
Shaffer AL, Wright G, Yang L, Powell J, Ngo V, Lamy L, Lam LT, Davis RE, Staudt LM. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunological Reviews. 210: 67-85. PMID 16623765 DOI: 10.1111/J.0105-2896.2006.00373.X |
0.484 |
|
| 2006 |
Spence SL, Shaffer AL, Staudt LM, Amde S, Manney S, Terry C, Weisz K, Nissley P. Transformation of late passage insulin-like growth factor-I receptor null mouse embryo fibroblasts by SV40 T antigen. Cancer Research. 66: 4233-9. PMID 16618746 DOI: 10.1158/0008-5472.Can-05-2257 |
0.325 |
|
| 2006 |
Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G, Lam LT, Dave S, Yang L, Powell J, Staudt LM. A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 441: 106-10. PMID 16572121 DOI: 10.1038/Nature04687 |
0.49 |
|
| 2006 |
Roberts RA, Wright G, Rosenwald AR, Jaramillo MA, Grogan TM, Miller TP, Frutiger Y, Chan WC, Gascoyne RD, Ott G, Muller-Hermelink HK, Staudt LM, Rimsza LM. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood. 108: 311-8. PMID 16543468 DOI: 10.1182/Blood-2005-11-4742 |
0.374 |
|
| 2006 |
Greiner TC, Dasgupta C, Ho VV, Weisenburger DD, Smith LM, Lynch JC, Vose JM, Fu K, Armitage JO, Braziel RM, Campo E, Delabie J, Gascoyne RD, Jaffe ES, Muller-Hermelink HK, ... ... Staudt LM, et al. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 103: 2352-7. PMID 16461462 DOI: 10.1073/Pnas.0510441103 |
0.403 |
|
| 2006 |
Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, ... ... Staudt LM, et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 961-8. PMID 16418494 DOI: 10.1200/Jco.2005.03.4264 |
0.472 |
|
| 2006 |
Rimsza LM, Roberts RA, Campo E, Grogan TM, Bea S, Salaverria I, Zettl A, Rosenwald A, Ott G, Muller-Hermelink HK, Delabie J, Fisher RI, Unger JM, Leblanc M, Staudt LM, et al. Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. Blood. 107: 1101-7. PMID 16239429 DOI: 10.1182/Blood-2005-04-1510 |
0.452 |
|
| 2006 |
Roberts RA, Rimsza LM, Staudt L, Rosenwald A, Chan W, Dave S, Gascoyne RD, Connors JM, Smeland EB, Muller-Hermelink H, Campo E, Jaffe ES, Wilson W, Tan BK, Fisher RI, et al. Gene Expression Differences between Low and High Stage Diffuse Large B Cell Lymphoma (DLBCL). Blood. 108: 809-809. DOI: 10.1182/Blood.V108.11.809.809 |
0.342 |
|
| 2006 |
Lenz G, Nagel I, Siebert R, Sanger W, Wright GW, Zhao H, Rosenwald A, Muller-Hermelink H, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, ... Staudt LM, et al. Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma. Blood. 108: 356-356. DOI: 10.1182/BLOOD.V108.11.356.356 |
0.355 |
|
| 2006 |
Dunleavy K, Pittaluga S, Janik J, Grant N, Shovlin M, Steinberg S, Raffeld M, Staudt L, Jaffe ES, Wilson WH. Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients. Blood. 108: 209-209. DOI: 10.1182/Blood.V108.11.209.209 |
0.303 |
|
| 2006 |
Wilson WH, Dunleavy K, Pittaluga S, Grant N, Shovlin M, Steinberg S, Raffeld M, Staudt L, Jaffe ES, Janik J. DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers. Blood. 108: 206-206. DOI: 10.1182/Blood.V108.11.206.206 |
0.391 |
|
| 2006 |
Hystad ME, Bo TH, Rian E, Myklebust JH, Sivertsen E, Forfang L, Chiorazzi M, Rosenwald A, Jonassen I, Staudt LM, Smeland EB. Characterization of Early Human B Cell Development by Gene Expression Profiling. Blood. 108: 1352-1352. DOI: 10.1182/Blood.V108.11.1352.1352 |
0.452 |
|
| 2005 |
Han SS, Shaffer AL, Peng L, Chung ST, Lim JH, Maeng S, Kim JS, McNeil N, Ried T, Staudt LM, Janz S. Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1. Molecular Cancer. 4: 40. PMID 16277667 DOI: 10.1186/1476-4598-4-40 |
0.496 |
|
| 2005 |
Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, ... ... Staudt LM, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 106: 4315-21. PMID 16123218 DOI: 10.1182/Blood-2005-04-1753 |
0.336 |
|
| 2005 |
Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling Advances in Immunology. 87: 163-208. PMID 16102574 DOI: 10.1016/S0065-2776(05)87005-1 |
0.524 |
|
| 2005 |
Rubio-Moscardo F, Blesa D, Mestre C, Siebert R, Balasas T, Benito A, Rosenwald A, Climent J, Martinez JI, Schilhabel M, Karran EL, Gesk S, Esteller M, deLeeuw R, Staudt LM, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood. 106: 3214-22. PMID 16051735 DOI: 10.1182/Blood-2005-05-2013 |
0.42 |
|
| 2005 |
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, ... ... Staudt LM, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 106: 3183-90. PMID 16046532 DOI: 10.1182/Blood-2005-04-1399 |
0.46 |
|
| 2005 |
Mestre C, Rubio-Moscardo F, Rosenwald A, Climent J, Dyer MJ, Staudt L, Pinkel D, Siebert R, Martinez-Climent JA. Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays. Leukemia. 19: 1082-4. PMID 15815722 DOI: 10.1038/Sj.Leu.2403741 |
0.433 |
|
| 2005 |
Lam LT, Davis RE, Pierce J, Hepperle M, Xu Y, Hottelet M, Nong Y, Wen D, Adams J, Dang L, Staudt LM. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 28-40. PMID 15671525 |
0.386 |
|
| 2005 |
Dunleavy K, Pittaluga S, Janik J, Grant N, Steinberg S, Staudt L, Jaffe E, Wilson WH. Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome Is Significantly Improved by the Addition of Rituximab to Dose Adjusted (DA)-EPOCH and Overcomes the Need for Radiation. Blood. 106: 929-929. DOI: 10.1182/Blood.V106.11.929.929 |
0.348 |
|
| 2005 |
Martinez-Delgado B, Bahl M, Cuadros M, Fernandez V, Benitez J, Jaffe ES, Staudt L. Biological Differences in Peripheral T-Cell Lymphomas Identified by DNA Microarrays. Blood. 106: 3012-3012. DOI: 10.1182/Blood.V106.11.3012.3012 |
0.42 |
|
| 2005 |
Iqbal J, Greiner TC, Patel K, Ji J, Dave BJ, Horsman DE, Shen Y, Weisenburger DD, Campo E, Rosenwald A, Gascoyne RD, Jaffe ES, Ott G, Delabie J, Rimsza L, ... ... Staudt LM, et al. Distinctive Patterns of BCL6 Molecular Alterations in Different Subsets of Diffuse Large B-Cell Lymphoma and Their Functional Consequences. Blood. 106: 160-160. DOI: 10.1182/Blood.V106.11.160.160 |
0.366 |
|
| 2004 |
Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P, Staudt LM, Schwaller J. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood. 105: 2891-9. PMID 15598810 DOI: 10.1182/Blood-2004-06-2297 |
0.468 |
|
| 2004 |
Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, ... ... Staudt LM, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. The New England Journal of Medicine. 351: 2159-69. PMID 15548776 DOI: 10.1056/Nejmoa041869 |
0.358 |
|
| 2004 |
Staudt LM. Cancer: negative feedback for B cells. Nature. 431: 919-20. PMID 15496906 DOI: 10.1038/431919A |
0.383 |
|
| 2004 |
Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, Sherman S, Dybkaer K, Zhou G, Eudy JD, Delabie J, McKeithan TW, Chan WC. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. Bmc Immunology. 5: 20. PMID 15369600 DOI: 10.1186/1471-2172-5-20 |
0.457 |
|
| 2004 |
Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, Hurt EM, Petroulakis E, Sonenberg N, Yewdell JW, Calame K, ... ... Staudt LM, et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity. 21: 81-93. PMID 15345222 DOI: 10.1016/J.Immuni.2004.06.010 |
0.622 |
|
| 2004 |
Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. Journal of Immunology (Baltimore, Md. : 1950). 173: 1158-65. PMID 15240705 DOI: 10.4049/Jimmunol.173.2.1158 |
0.4 |
|
| 2004 |
de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, Staudt LM, Martinez-Climent JA, Lam WL. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Human Molecular Genetics. 13: 1827-37. PMID 15229187 DOI: 10.1093/Hmg/Ddh195 |
0.349 |
|
| 2004 |
Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, ... ... Staudt LM, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. The American Journal of Pathology. 165: 159-66. PMID 15215171 DOI: 10.1016/S0002-9440(10)63284-1 |
0.443 |
|
| 2004 |
Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leukemia & Lymphoma. S41-7. PMID 15202524 DOI: 10.1080/10428190310001623775 |
0.522 |
|
| 2004 |
Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, Plebani A, Kumararatne DS, Bonnet D, Tournilhac O, Tchernia G, Steiniger B, Staudt LM, Casanova JL, Reynaud CA, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 104: 3647-54. PMID 15191950 DOI: 10.1182/Blood-2004-01-0346 |
0.429 |
|
| 2004 |
Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood. 104: 1428-34. PMID 15138159 DOI: 10.1182/Blood-2003-09-3236 |
0.426 |
|
| 2004 |
Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. Journal of Virology. 78: 4108-19. PMID 15047827 DOI: 10.1128/Jvi.78.8.4108-4119.2004 |
0.472 |
|
| 2004 |
Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell. 5: 191-9. PMID 14998494 DOI: 10.1016/S1535-6108(04)00019-4 |
0.318 |
|
| 2004 |
Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, ... ... Staudt LM, et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood. 103: 4251-8. PMID 14976040 DOI: 10.1182/Blood-2003-07-2365 |
0.409 |
|
| 2004 |
Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 363: 105-11. PMID 14726163 DOI: 10.1016/S0140-6736(03)15260-9 |
0.395 |
|
| 2004 |
Wiestner A, Staudt LM. Towards molecular diagnosis and targeted therapy of lymphoid malignancies. Seminars in Hematology. 40: 296-307. PMID 14582080 DOI: 10.1016/S0037-1963(03)00194-X |
0.494 |
|
| 2004 |
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, ... ... Staudt LM, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 103: 275-82. PMID 14504078 DOI: 10.1182/Blood-2003-05-1545 |
0.43 |
|
| 2004 |
Wiestner A, Chiorazzi M, Lai R, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, ... ... Staudt LM, et al. High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA. Blood. 104: 697-697. DOI: 10.1182/Blood.V104.11.697.697 |
0.368 |
|
| 2004 |
Zettl A, Bea S, Wright G, Salaverria I, Jehn P, Ott G, Chan W, Jaffe E, Weisenburger D, Greiner T, Armitage J, Gascoyne R, Connors J, Grogan T, Miller T, ... ... Staudt L, et al. Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work). Blood. 104: 415-415. DOI: 10.1182/Blood.V104.11.415.415 |
0.425 |
|
| 2004 |
Lee A, Davies A, Clear A, Calaminici M, Matthews J, Norton A, Wright G, Staudt LM, Fitzgibbon J, Lister TA, Goff L. Tissue Microarray Is a Useful Tool in the Evaluation of Genes Implicated in Transformation of Follicular Lymphoma. Blood. 104: 2267-2267. DOI: 10.1182/Blood.V104.11.2267.2267 |
0.349 |
|
| 2004 |
Wilson WH, Dunleavy K, Pittaluga S, Grant N, Steinberg S, Raffeld M, Chabner B, Grossbard M, Jaffe E, Staudt L, Janik J. Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma. Blood. 104: 159-159. DOI: 10.1182/Blood.V104.11.159.159 |
0.383 |
|
| 2004 |
Zettl A, Bea S, Rosenwald A, Jehn P, Salaverria I, Ott G, Staudt L, Müller-Hermelink H, Campo E. Germinal center B-cell-like and activated B-cell like diffuse large B-cell lymphoma are genetically distinct Pathology - Research and Practice. 200: 343. DOI: 10.1016/S0344-0338(04)80725-8 |
0.331 |
|
| 2003 |
McConnell MJ, Chevallier N, Berkofsky-Fessler W, Giltnane JM, Malani RB, Staudt LM, Licht JD. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Molecular and Cellular Biology. 23: 9375-88. PMID 14645547 DOI: 10.1128/Mcb.23.24.9375-9388.2003 |
0.391 |
|
| 2003 |
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, ... ... Staudt LM, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. The Journal of Experimental Medicine. 198: 851-62. PMID 12975453 DOI: 10.1084/Jem.20031074 |
0.506 |
|
| 2003 |
Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 100: 9991-6. PMID 12900505 DOI: 10.1073/Pnas.1732008100 |
0.49 |
|
| 2003 |
Pan Z, Shen Y, Du C, Zhou G, Rosenwald A, Staudt LM, Greiner TC, McKeithan TW, Chan WC. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. The American Journal of Pathology. 163: 135-44. PMID 12819018 DOI: 10.1016/S0002-9440(10)63637-1 |
0.514 |
|
| 2003 |
Staudt LM. Molecular diagnosis of the hematologic cancers. The New England Journal of Medicine. 348: 1777-85. PMID 12724484 DOI: 10.1056/Nejmra020067 |
0.357 |
|
| 2003 |
Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, ... ... Staudt LM, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 3: 185-97. PMID 12620412 DOI: 10.1016/S1535-6108(03)00028-X |
0.45 |
|
| 2003 |
Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, ... ... Staudt LM, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 101: 4944-51. PMID 12595313 DOI: 10.1182/Blood-2002-10-3306 |
0.401 |
|
| 2003 |
Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de Thé H, Bazarbachi A. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood. 101: 4576-82. PMID 12560223 DOI: 10.1182/Blood-2002-09-2986 |
0.432 |
|
| 2003 |
Sanchez-Izquierdo D, Buchonnet G, Siebert R, Gascoyne RD, Climent J, Karran L, Marin M, Blesa D, Horsman D, Rosenwald A, Staudt LM, Albertson DG, Du MQ, Ye H, Marynen P, et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood. 101: 4539-46. PMID 12560219 DOI: 10.1182/Blood-2002-10-3236 |
0.445 |
|
| 2003 |
Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nature Reviews. Immunology. 2: 920-32. PMID 12461565 DOI: 10.1038/Nri953 |
0.479 |
|
| 2003 |
Staudt LM, Wilson WH. Focus on lymphomas. Cancer Cell. 2: 363-6. PMID 12450791 DOI: 10.1016/S1535-6108(02)00178-2 |
0.375 |
|
| 2002 |
Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway. Oncogene. 21: 8759-68. PMID 12483529 DOI: 10.1038/Sj.Onc.1206033 |
0.411 |
|
| 2002 |
Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17: 51-62. PMID 12150891 DOI: 10.1016/S1074-7613(02)00335-7 |
0.495 |
|
| 2002 |
Staudt LM. It's ALL in the diagnosis. Cancer Cell. 1: 109-10. PMID 12086866 DOI: 10.1016/S1535-6108(02)00036-3 |
0.345 |
|
| 2002 |
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, ... ... Staudt LM, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. The New England Journal of Medicine. 346: 1937-47. PMID 12075054 DOI: 10.1056/Nejmoa012914 |
0.499 |
|
| 2002 |
Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Seminars in Oncology. 29: 258-63. PMID 12063678 DOI: 10.1053/Sonc.2002.32901 |
0.472 |
|
| 2002 |
Davis RE, Staudt LM. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Current Opinion in Hematology. 9: 333-8. PMID 12042708 DOI: 10.1097/00062752-200207000-00011 |
0.487 |
|
| 2002 |
Wilson WH, Grossbard ML, Pittaluga S, Cole D, Pearson D, Drbohlav N, Steinberg SM, Little RF, Janik JE, Gutierrez M, Raffeld M, Staudt L, Cheson BD, Longo DL, Harris N, et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy Blood. 99: 2685-2693. PMID 11929754 DOI: 10.1182/Blood.V99.8.2685 |
0.369 |
|
| 2002 |
Huang JZ, Sanger WG, Greiner TC, Staudt LM, Weisenburger DD, Pickering DL, Lynch JC, Armitage JO, Warnke RA, Alizadeh AA, Lossos IS, Levy R, Chan WC. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood. 99: 2285-90. PMID 11895757 DOI: 10.1182/Blood.V99.7.2285 |
0.465 |
|
| 2002 |
Staudt LM. Gene expression profiling of lymphoid malignancies. Annual Review of Medicine. 53: 303-18. PMID 11818476 DOI: 10.1146/Annurev.Med.53.082901.103941 |
0.479 |
|
| 2002 |
Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proceedings of the National Academy of Sciences of the United States of America. 99: 972-7. PMID 11805339 DOI: 10.1073/Pnas.231625398 |
0.311 |
|
| 2002 |
van der Pouw Kraan T, van Gaalen F, Kasperkovitz P, Verbeet N, Alizadeh A, Fero M, Huizinga T, Pieterman E, Breedveld F, Staudt L, Botstein D, Brown P, Verweij C. Arthritis Research. 4: 28. DOI: 10.1186/Ar468 |
0.356 |
|
| 2001 |
Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. The Journal of Experimental Medicine. 194: 1861-74. PMID 11748286 DOI: 10.1084/Jem.194.12.1861 |
0.518 |
|
| 2001 |
Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, ... ... Staudt LM, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. The Journal of Experimental Medicine. 194: 1639-47. PMID 11733578 DOI: 10.1084/Jem.194.11.1639 |
0.485 |
|
| 2001 |
Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, Pickeral OK, Staudt LM. Signatures of the immune response Immunity. 15: 375-385. PMID 11567628 DOI: 10.1016/S1074-7613(01)00194-7 |
0.491 |
|
| 2001 |
Siebert R, Rosenwald A, Staudt LM, Morris SW. Molecular features of B-cell lymphoma. Current Opinion in Oncology. 13: 316-24. PMID 11555707 DOI: 10.1097/00001622-200109000-00002 |
0.465 |
|
| 2001 |
Boehm J, He Y, Greiner A, Staudt L, Wirth T. Regulation of BOB.1/OBF.1 stability by SIAH. The Embo Journal. 20: 4153-62. PMID 11483518 DOI: 10.1093/Emboj/20.15.4153 |
0.76 |
|
| 2001 |
Staudt LM. Gene expression physiology and pathophysiology of the immune system. Trends in Immunology. 22: 35-40. PMID 11286690 DOI: 10.1016/S1471-4906(00)01792-0 |
0.377 |
|
| 2001 |
Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes Nature Immunology. 2: 316-324. PMID 11276202 DOI: 10.1038/86318 |
0.408 |
|
| 2001 |
Ma C, Staudt LM. Molecular definition of the germinal centre stage of B-cell differentiation. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 356: 83-9. PMID 11205335 DOI: 10.1098/Rstb.2000.0752 |
0.475 |
|
| 2000 |
Hastie T, Tibshirani R, Eisen MB, Alizadeh A, Levy R, Staudt L, Chan WC, Botstein D, Brown P. 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biology. 1: RESEARCH0003. PMID 11178228 DOI: 10.1186/Gb-2000-1-2-Research0003 |
0.362 |
|
| 2000 |
Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 13: 199-212. PMID 10981963 DOI: 10.1016/S1074-7613(00)00020-0 |
0.784 |
|
| 2000 |
Meffre E, Davis E, Schiff C, Cunningham-Rundles C, Ivashkiv LB, Staudt LM, Young JW, Nussenzweig MC. Circulating human B cells that express surrogate light chains and edited receptors. Nature Immunology. 1: 207-13. PMID 10973277 DOI: 10.1038/79739 |
0.418 |
|
| 2000 |
Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D, Staudt LM, Levy R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 97: 10209-13. PMID 10954754 DOI: 10.1073/Pnas.180316097 |
0.511 |
|
| 2000 |
Staudt LM, Brown PO. Genomic views of the immune system Annual Review of Immunology. 18: 829-859. PMID 10837077 DOI: 10.1146/Annurev.Immunol.18.1.829 |
0.388 |
|
| 2000 |
Alizadeh AA, Staudt LM. Genomic-scale gene expression profiling of normal and malignant immune cells. Current Opinion in Immunology. 12: 219-25. PMID 10712950 DOI: 10.1016/S0952-7915(99)00078-3 |
0.423 |
|
| 2000 |
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, ... ... Staudt LM, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403: 503-11. PMID 10676951 DOI: 10.1038/35000501 |
0.507 |
|
| 2000 |
Staudt LM, Dent AL, Shaffer AL, Yu X. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. International Reviews of Immunology. 18: 381-403. PMID 10626250 DOI: 10.3109/08830189909088490 |
0.489 |
|
| 1999 |
Alizadeh A, Eisen M, Davis RE, Ma C, Sabet H, Tran T, Powell JI, Yang L, Marti GE, Moore DT, Hudson JR, Chan WC, Greiner T, Weisenburger D, Armitage JO, ... ... Staudt LM, et al. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Symposia On Quantitative Biology. 64: 71-8. PMID 11232339 DOI: 10.1101/Sqb.1999.64.71 |
0.356 |
|
| 1999 |
Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. The transcriptional program in the response of human fibroblasts to serum. Science (New York, N.Y.). 283: 83-7. PMID 9872747 DOI: 10.1126/Science.283.5398.83 |
0.312 |
|
| 1999 |
Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He W, Ricciardi-Castagnoli P, Rosen CA, Carter KC. Reed-Sternberg Cell Genome Expression Supports a B-Cell Lineage Blood. 94: 411-416. DOI: 10.1182/Blood.V94.2.411.414K47_411_416 |
0.469 |
|
| 1999 |
Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He W, Ricciardi-Castagnoli P, Rosen CA, Carter KC. Reed-Sternberg Cell Genome Expression Supports a B-Cell Lineage Blood. 94: 411-416. DOI: 10.1182/blood.V94.2.411 |
0.365 |
|
| 1999 |
Yang L, Powell J, Alizadeh A, Davis RE, Ma C, Sabet H, Tran T, Staudt LM. Building lymphochip-computational algorithms for selecting clones highly expressed in B cell cDNA libraries Nature Genetics. 23: 83-83. DOI: 10.1038/14431 |
0.352 |
|
| 1999 |
Cossman J, Vockley J, Carter K, Ruben S, Staudt L, Barash S, Birse C, Rosen C, Dolginow D, Lennon G. Genome-wide gene expression of the rare, malignant Reed-Sternberg cellof Hodgkin lymphoma Nature Genetics. 23: 40-40. DOI: 10.1038/14289 |
0.466 |
|
| 1999 |
Alizadeh A, Eisen MB, Davis RE, Powell JI, Yang L, Hart RR, Sabet H, Tran TH, Yu X, Ma C, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Lossos I, ... ... Staudt LM, et al. Analysis of gene expression in normal and malignant lymphocytes using the Lymphochip cDNA microarray Nature Genetics. 23: 30-31. DOI: 10.1038/14260 |
0.384 |
|
| 1999 |
Staudt LM. Analysis of gene expression in lymphoid malignancies using the Lymphochip cDNA microarray Nature Genetics. 23: 22-22. DOI: 10.1038/14242 |
0.377 |
|
| 1998 |
Alizadeh A, Eisen M, Botstein D, Brown PO, Staudt LM. Probing lymphocyte biology by genomic-scale gene expression analysis Journal of Clinical Immunology. 18: 373-379. PMID 9857281 DOI: 10.1023/A:1023293621057 |
0.438 |
|
| 1998 |
Dent AL, Hu-Li J, Paul WE, Staudt LM. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proceedings of the National Academy of Sciences of the United States of America. 95: 13823-8. PMID 9811885 DOI: 10.1073/Pnas.95.23.13823 |
0.317 |
|
| 1997 |
Yin L, Schwartzberg P, Scharton-kerstenj TM, Staudt L, Lenardo M. Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases Molecular Immunology. 34: 481-491. PMID 9307064 DOI: 10.1016/S0161-5890(97)00053-9 |
0.377 |
|
| 1997 |
Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science (New York, N.Y.). 276: 589-92. PMID 9110977 DOI: 10.1126/Science.276.5312.589 |
0.406 |
|
| 1996 |
Behrens TW, Kearns GM, Rivard JJ, Bernstein HD, Yewdell JW, Staudt LM. Carboxyl-terminal targeting and novel post-translational processing of JAW1, a lymphoid protein of the endoplasmic reticulum Journal of Biological Chemistry. 271: 23528-23534. PMID 8798562 DOI: 10.1074/Jbc.271.38.23528 |
0.468 |
|
| 1996 |
Vigano MA, Staudt LM. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. Nucleic Acids Research. 24: 2112-8. PMID 8668543 DOI: 10.1093/Nar/24.11.2112 |
0.344 |
|
| 1996 |
Seyfert VL, Allman D, He Y, Staudt LM. Transcriptional repression by the proto-oncogene BCL-6. Oncogene. 12: 2331-42. PMID 8649773 |
0.726 |
|
| 1996 |
Dent A, Yewdell J, Puvion-Dutilleul F, Koken M, de The H, Staudt L. LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies Blood. 88: 1423-1426. DOI: 10.1182/Blood.V88.4.1423.Bloodjournal8841423 |
0.519 |
|
| 1996 |
Ma C, Staudt L. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias Blood. 87: 734-745. DOI: 10.1182/Blood.V87.2.734.Bloodjournal872734 |
0.409 |
|
| 1996 |
Allman D, Jain A, Dent A, Maile R, Selvaggi T, Kehry M, Staudt L. BCL-6 expression during B-cell activation Blood. 87: 5257-5268. DOI: 10.1182/Blood.V87.12.5257.Bloodjournal87125257 |
0.45 |
|
| 1995 |
Staudt LM, Dent A, Ma C, Allman D, Powell J, Maile R, Scherle P, Behrens T. Rapid identification of novel human lymphoid-restricted genes by automated DNA sequencing of subtracted cDNA libraries. Current Topics in Microbiology and Immunology. 194: 155-61. PMID 7895489 DOI: 10.1007/978-3-642-79275-5_19 |
0.45 |
|
| 1993 |
Scherle P, Behrens T, Staudt LM. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 90: 7568-72. PMID 8356058 DOI: 10.1073/Pnas.90.16.7568 |
0.391 |
|
| 1992 |
Kang SM, Tsang W, Doll S, Scherle P, Ko HS, Tran AC, Lenardo MJ, Staudt LM. Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Molecular and Cellular Biology. 12: 3149-54. PMID 1620122 DOI: 10.1128/Mcb.12.7.3149 |
0.398 |
|
| 1991 |
Kavaler J, Caton AJ, Staudt LM, Gerhard W. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. European Journal of Immunology. 21: 2687-95. PMID 1936117 DOI: 10.1002/Eji.1830211107 |
0.663 |
|
| 1991 |
Staudt LM, Lenardo MJ. Immunoglobulin gene transcription. Annual Review of Immunology. 9: 373-98. PMID 1910683 DOI: 10.1146/Annurev.Iy.09.040191.002105 |
0.401 |
|
| 1991 |
Caton AJ, Stark SE, Kavaler J, Staudt LM, Schwartz D, Gerhard W. Many variable region genes are utilized in the antibody response of BALB/c mice to the influenza virus A/PR/8/34 hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). 147: 1675-86. PMID 1908881 |
0.599 |
|
| 1990 |
Clarke S, Rickert R, Wloch MK, Staudt L, Gerhard W, Weigert M. The BALB/c secondary response to the Sb site of influenza virus hemagglutinin: Nonrandom silent mutation and unequal numbers of VH and Vk mutations Journal of Immunology. 145: 2286-2296. PMID 2398280 |
0.609 |
|
| 1990 |
Kavaler J, Caton AJ, Staudt LM, Schwartz D, Gerhard W. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). 145: 2312-21. PMID 2118933 |
0.604 |
|
| 1990 |
Clarke SH, Staudt LM, Kavaler J, Schwartz D, Gerhard WU, Weigert MG. V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). 144: 2795-801. PMID 2108213 |
0.588 |
|
| 1990 |
Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 345: 686-92. PMID 1972777 DOI: 10.1038/345686A0 |
0.397 |
|
| 1990 |
Petryniak B, Staudt LM, Postema CE, McCormack WT, Thompson CB. Characterization of chicken octamer-binding proteins demonstrates that POU domain-containing homeobox transcription factors have been highly conserved during vertebrate evolution. Proceedings of the National Academy of Sciences of the United States of America. 87: 1099-103. PMID 1967834 DOI: 10.1073/Pnas.87.3.1099 |
0.363 |
|
| 1989 |
Lenardo MJ, Staudt L, Robbins P, Kuang A, Mulligan RC, Baltimore D. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. Science (New York, N.Y.). 243: 544-6. PMID 2536195 DOI: 10.1126/Science.2536195 |
0.636 |
|
| 1988 |
Staudt LM, Clerc RG, Singh H, LeBowitz JH, Sharp PA, Baltimore D. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif Science. 241: 577-580. PMID 3399892 DOI: 10.1126/Science.3399892 |
0.664 |
|
| 1988 |
LeBowitz JH, Kobayashi T, Staudt L, Baltimore D, Sharp PA. Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy-chain promoter in vitro Genes &Amp; Development. 2: 1227-1237. PMID 3264542 DOI: 10.1101/Gad.2.10.1227 |
0.518 |
|
| 1987 |
Wirth T, Staudt L, Baltimore D. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature. 329: 174-8. PMID 3627254 DOI: 10.1038/329174A0 |
0.493 |
|
| 1986 |
Staudt LM, Singh H, Sen R, Wirth T, Sharp PA, Baltimore D. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature. 323: 640-3. PMID 3095662 DOI: 10.1038/323640A0 |
0.588 |
|
| 1986 |
Caton AJ, Brownlee GG, Staudt LM, Gerhard W. Structural and functional implications of a restricted antibody response to a defined antigenic region on the influenza virus hemagglutinin. The Embo Journal. 5: 1577-87. PMID 2427335 DOI: 10.1002/J.1460-2075.1986.Tb04399.X |
0.618 |
|
| 1985 |
Clarke SH, Huppi K, Ruezinsky D, Staudt L, Gerhard W, Weigert M. Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin Journal of Experimental Medicine. 161: 687-704. PMID 3920342 DOI: 10.1084/Jem.161.4.687 |
0.616 |
|
| 1984 |
Huppi K, Julius M, Staudt L, Gerhard W, Weigert M. The idiotypes of Vκ21 light chains Annales De L'Institut Pasteur/Actualites. 135: 181-185. PMID 6424552 DOI: 10.1016/S0769-2625(84)80030-6 |
0.555 |
|
| 1984 |
McKean D, Huppi K, Bell M, Staudt L, Gerhard W, Weigert M. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin Proceedings of the National Academy of Sciences of the United States of America. 81: 3180-3184. PMID 6203114 DOI: 10.1073/Pnas.81.10.3180 |
0.607 |
|
| 1983 |
Staudt LM, Gerhard W. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. The Journal of Experimental Medicine. 157: 687-704. PMID 6600489 DOI: 10.1084/Jem.157.2.687 |
0.587 |
|
| Show low-probability matches. |
